Improving the regenerative potential of olfactory ensheathing cells by overexpressing prostacyclin synthetase and its application in spinal cord repair Abstract Background : Olfactory ensheathing cells -LRB- OEC -RRB- , specialized glia that ensheathe bundles of olfactory nerves , have been reported as a favorable substrate for axonal regeneration .	1
Improving the regenerative potential of olfactory ensheathing cells by overexpressing prostacyclin synthetase and its application in spinal cord repair Abstract Background	1
Improving the regenerative potential	1
Improving	1
the regenerative potential	11
olfactory ensheathing cells by overexpressing prostacyclin synthetase and its application in spinal cord repair Abstract Background	41
olfactory ensheathing cells	41
overexpressing prostacyclin synthetase and its application in spinal cord repair Abstract Background	72
overexpressing prostacyclin synthetase	72
its application in spinal cord repair Abstract Background	115
its application	115
spinal cord repair Abstract Background	134
Olfactory ensheathing cells -LRB- OEC -RRB- , specialized glia that ensheathe bundles of olfactory nerves ,	175
Olfactory ensheathing cells	175
OEC	204
specialized glia that ensheathe bundles of olfactory nerves	210
specialized glia	210
bundles of olfactory nerves	242
bundles	242
olfactory nerves	253
a favorable substrate for axonal regeneration	293
a favorable substrate	293
axonal regeneration	319
Grafting OEC to injured spinal cord	340
Grafting OEC	340
injured spinal cord	356
axonal regeneration	398
the functional recovery	427
an attempt to improve the growth-promoting properties of OEC	466
the growth-promoting properties of OEC	488
the growth-promoting properties	488
OEC	523
we	528
prostacyclin synthase -LRB- PGIS -RRB-	542
prostacyclin synthase	542
PGIS	565
OEC via adenoviral -LRB- Ad -RRB- gene transfer	574
OEC	574
adenoviral -LRB- Ad -RRB- gene transfer	582
Ad	594
the effect of OEC	625
the effect	625
OEC	639
enhanced prostacyclin synthesis in co-culture and in vivo	648
enhanced prostacyclin synthesis	648
co-culture	683
Prostacyclin	707
a vasodilator , platelet anti-aggregatory and cytoprotective agent	723
a vasodilator	723
platelet anti-aggregatory and cytoprotective agent	738
Results	790
OEC	808
high level of cyclooxygneases , but not PGIS	822
high level	822
cyclooxygneases , but not PGIS	836
cyclooxygneases	836
PGIS	861
Infection of AdPGIS to OEC	867
Infection	867
AdPGIS to OEC	880
AdPGIS	880
OEC	890
prostacyclin synthesis	921
either OEC or AdPGIS-OEC	966
OEC	973
AdPGIS-OEC	980
neuronal cells	992
OGD-induced damage	1025
The	1045
OEC	1058
further transplanted to the transected cavity of thoracic spinal cord injured -LRB- SCI -RRB- rats	1067
further	1067
the transected cavity of thoracic spinal cord injured -LRB- SCI -RRB- rats	1091
the transected cavity	1091
thoracic spinal cord injured -LRB- SCI -RRB- rats	1116
thoracic spinal cord	1116
-LRB- SCI -RRB- rats	1145
SCI	1146
6 weeks	1160
significant functional recovery in hind limbs	1182
significant functional recovery	1182
hind limbs	1217
OEC or AdPGIS-OEC transplanted SCI rats compared with nontreated SCI rats	1240
OEC or AdPGIS-OEC	1240
SCI rats	1271
nontreated SCI rats	1294
10 -- 12 weeks postgraft	1318
10	1318
12 weeks postgraft	1321
12 weeks	1321
postgraft	1330
AdPGIS-OEC transplanted SCI rats	1341
AdPGIS-OEC	1341
SCI rats	1365
better motor restoration than OEC	1395
better motor restoration	1395
OEC	1425
transplanted SCI rats	1429
regenerating fiber tracts in the distal spinal cord stump	1464
regenerating fiber tracts	1464
the distal spinal cord stump	1493
40	1536
60 % of AdPGIS-OEC transplanted SCI rats	1539
60 %	1539
AdPGIS-OEC transplanted SCI rats	1546
AdPGIS-OEC	1546
SCI rats	1570
Conclusions : Enhanced synthesis of prostacyclin in grafted OEC improved fiber tract regeneration and functional restoration in spinal cord injured rats .	1580
Conclusions	1580
synthesis of prostacyclin	1602
synthesis	1602
prostacyclin	1615
grafted OEC	1631
fiber tract regeneration and functional restoration in spinal cord injured rats	1652
fiber tract regeneration and functional restoration	1652
spinal cord injured rats	1707
spinal cord	1707
rats	1727
These results	1733
an important potential of prostacyclin	1755
an important potential	1755
prostacyclin	1781
OEC therapeutic properties that are relevant for neural transplant therapies	1809
OEC therapeutic properties	1809
neural transplant therapies	1858
Background Complete transection of the adult mammalian spinal cord	1888
Background Complete transection	1888
the adult mammalian spinal cord	1923
irreversible and permanent loss of motor and somatosensory function	1966
irreversible and permanent loss	1966
motor and somatosensory function	2001
the injury site -LSB- 1 -- 3 -RSB-	2040
the injury site	2040
1 -- 3	2057
The inhospitable environment and lack of spontaneous regeneration of injured central axons	2063
The inhospitable environment and lack	2063
spontaneous regeneration of injured central axons	2104
spontaneous regeneration	2104
injured central axons	2132
permanent functional impairment	2162
the adult SCI victims -LSB- 4	2197
the adult SCI victims	2197
4	2220
6 -RSB-	2222
this	2235
the olfactory bulb	2258
The growth permissive olfactory bulbs	2278
The growth	2278
permissive olfactory bulbs	2289
the presence of olfactory ensheathing cells -LRB- OEC -RRB- , the distinct glia of the primary olfactory nerve with both Schwann cell-like and astrocyte-like characteristics -LSB- 7 -- 10 -RSB-	2327
the presence	2327
olfactory ensheathing cells -LRB- OEC -RRB- , the distinct glia of the primary olfactory nerve with both Schwann cell-like and astrocyte-like characteristics -LSB- 7 -- 10 -RSB-	2343
olfactory ensheathing cells -LRB- OEC -RRB-	2343
olfactory ensheathing cells	2343
OEC	2372
the distinct glia of the primary olfactory nerve with both Schwann cell-like and astrocyte-like characteristics -LSB- 7 -- 10 -RSB-	2378
the distinct glia	2378
the primary olfactory nerve with both Schwann cell-like and astrocyte-like characteristics -LSB- 7 -- 10 -RSB-	2399
the primary olfactory nerve	2399
both Schwann cell-like and astrocyte-like characteristics -LSB- 7 -- 10 -RSB-	2432
Schwann cell-like and astrocyte-like characteristics	2437
Schwann	2437
cell-like and astrocyte-like characteristics	2445
7	2491
10 -RSB-	2493
The presence of OEC	2498
The presence	2498
OEC	2514
support	2540
growing axons of olfactory sensory neurons to cross the transition zone between PNS and CNS and extend processes in the olfactory bulb without inhibition -LSB- 9 -- 12 -RSB-	2558
growing axons	2558
olfactory sensory neurons	2575
the transition zone between PNS and CNS	2610
the transition zone	2610
PNS and CNS	2638
processes in the olfactory bulb	2661
processes	2661
the olfactory bulb	2674
inhibition -LSB- 9 -- 12 -RSB-	2701
inhibition	2701
9 -- 12	2713
Several groups	2720
OEC transplant	2745
axonal elongation	2773
different injured CNS regions -LSB- 13 -- 17 -RSB-	2794
different injured CNS regions	2794
13 -- 17	2825
implantation in the spinal cord	2839
implantation	2839
the spinal cord	2855
OEC	2872
a less severe host astrocyte response than Schwann cells	2884
a less severe host astrocyte response	2884
Schwann cells	2927
18 -RSB-	2942
OEC transplantation	2953
a promising treatment for spinal cord injury	2987
a promising treatment	2987
spinal cord injury	3013
the improvement of functional recovery	3042
the improvement	3042
functional recovery	3061
-LSB- 14 , 19 , 20 -RSB-	3092
Overexpression of neuroprotective genes	3106
Overexpression	3106
neuroprotective genes	3124
a promising strategy to promote regeneration of injured axon	3152
regeneration of injured axon	3184
regeneration	3184
injured axon	3200
an attempt to further increase the growth	3217
an attempt	3217
further increase the growth	3231
further increase	3231
the growth	3248
effect of OEC	3269
effect	3269
OEC	3279
the present study	3284
ex vivo adenovirus-mediated gene transfer of protacyclin synthase -LRB- PGIS -RRB- in OEC	3310
ex vivo adenovirus-mediated gene	3310
protacyclin synthase -LRB- PGIS -RRB-	3355
protacyclin synthase	3355
PGIS	3377
OEC	3386
prostacyclin synthesis	3404
Prostacyclin -LRB- prostaglandin -LRB- PG -RRB- I2 -RRB-	3428
Prostacyclin	3428
prostaglandin -LRB- PG -RRB- I2	3442
prostaglandin -LRB- PG -RRB-	3442
prostaglandin	3442
PG	3457
I2	3461
a primary vasodilator	3473
an inhibitor of leukocyte adhesion and platelet aggregation -LSB- 21 , 22 -RSB-	3502
an inhibitor	3502
leukocyte adhesion and platelet aggregation -LSB- 21	3518
leukocyte adhesion and platelet aggregation	3518
21	3563
PGI2	3572
the sequential action of cyclooxygenase -LRB- COX -RRB- -1 or − 2 and prostacyclin synthase from arachidonic acid -LRB- AA -RRB- which is deacylated from cellular phospholipids -LSB- 23 -RSB-	3595
the sequential action	3595
cyclooxygenase -LRB- COX -RRB- -1 or − 2 and prostacyclin synthase from arachidonic acid -LRB- AA -RRB- which is deacylated from cellular phospholipids -LSB- 23 -RSB-	3620
cyclooxygenase -LRB- COX -RRB-	3620
cyclooxygenase	3620
COX	3636
-1 or − 2	3640
prostacyclin synthase from arachidonic acid -LRB- AA -RRB- which is deacylated from cellular phospholipids -LSB- 23 -RSB-	3653
prostacyclin synthase	3653
arachidonic acid -LRB- AA -RRB- which is deacylated from cellular phospholipids -LSB- 23 -RSB-	3680
arachidonic acid	3680
AA	3698
cellular phospholipids -LSB- 23 -RSB-	3727
cellular phospholipids	3727
23 -RSB-	3751
Prostaglandin or leukotriene	3756
tissue injury or inflammation -LSB- 24 -RSB-	3817
tissue injury or inflammation	3817
24 -RSB-	3848
Prostacyclin or its CNS analogs	3853
Prostacyclin	3853
its CNS analogs	3869
infarct volume	3914
ischemic rat brains	3932
-LSB- 25 , 26 -RSB-	3952
Administration of prostacyclin	3962
Administration	3962
prostacyclin	3980
the cortical lesion	4015
rats	4038
traumatic brain injury -LSB- 27 -RSB-	4048
traumatic brain injury	4048
27 -RSB-	4072
Lin et al. , -LSB- 25 -RSB- and our recent articles -LSB- 28 , 29 -RSB-	4077
Lin et al.	4077
Lin	4077
et al.	4081
25 -RSB- and our recent articles	4090
25 -RSB-	4090
our recent articles	4098
-LSB- 28 , 29	4118
beneficial effects of enhanced prostacyclin synthesis	4145
beneficial effects	4145
enhanced prostacyclin synthesis	4167
neuronal cultures	4202
Parkinsonian or ischemic brains	4234
Parkinsonian	4234
ischemic brains	4250
multiple sclerosis	4270
vessels-derived prostacyclin	4290
axonal remodeling of injured neuronal networks	4336
axonal remodeling	4336
injured neuronal networks	4357
CST fibers	4408
the repair process -LSB- 30 -RSB-	4436
the repair process	4436
30 -RSB-	4456
Prostacyclin	4461
remyelination and functional recovery	4488
mice	4529
spinal nerve demyelination -LSB- 31 -RSB-	4540
spinal nerve demyelination	4540
31 -RSB-	4568
These findings	4573
us	4597
the possibility	4608
prostacyclin	4629
spinal nerve regeneration	4657
We	4684
recombinant adenovirus vectors -LRB- Ad -RRB-	4704
recombinant adenovirus vectors	4704
Ad	4736
green fluorescence protein -LRB- GFP -RRB- , COX-1 , COX-2 or PGIS ,	4749
green fluorescence protein -LRB- GFP -RRB-	4749
green fluorescence protein	4749
GFP	4777
COX-1 , COX-2 or PGIS	4783
stable delivery of individual gene in infected cells	4818
stable delivery	4818
individual gene in infected cells	4837
individual gene	4837
infected cells	4856
combinational infection of AdCOX-1 and/or AdPGIS	4875
combinational infection	4875
AdCOX-1 and/or AdPGIS	4902
AdCOX-1	4902
AdPGIS	4917
we	4925
prostacyclin production in endothelial cells	4954
prostacyclin production	4954
endothelial cells	4981
-LSB- 32 , 33	4999
CNS cells	5014
-LSB- 28 , 29 -RSB-	5024
The present work	5034
the effects of augmented prostacyclin production in OEC	5066
the effects	5066
augmented prostacyclin production in OEC	5081
augmented prostacyclin production	5081
OEC	5118
adenoviral gene transfter on survival and regeneration of spinal axons	5125
adenoviral gene transfter	5125
survival and regeneration of spinal axons	5154
survival and regeneration	5154
spinal axons	5183
transplantation of AdPGIS-OEC	5202
transplantation	5202
AdPGIS-OEC	5221
thoracic T8-transected spinal cord	5235
Our goal	5271
an environment	5294
spinal nerve regrowth after spinal cord injury	5327
spinal nerve regrowth	5327
spinal cord injury	5355
Methods	5375
Reagents and antibodies Cultured medium	5383
Reagents and antibodies	5383
fetal bovine serum -LRB- FBS -RRB-	5424
fetal bovine serum	5424
FBS	5444
serumfree supplements and antibiotics	5450
Invitrogen -LRB- Carlsbad , CA , USA -RRB-	5508
Invitrogen	5508
Carlsbad	5520
CA	5530
USA	5534
Tissue culture plastics	5540
BD Bioscience -LRB- San Jose , CA , USA -RRB-	5574
BD Bioscience	5574
San Jose	5589
CA	5599
USA	5603
Millicell culture inserts	5609
Millipore -LRB- Watford , UK -RRB-	5645
Millipore	5645
Watford	5656
UK	5665
Primary antibodies used in the present study were : rabbit or mouse antineuronal class III beta tubulin -LRB- clone TUJ-1 , Covance , NJ , USA -RRB- , rabbit anti-GFAP or anti-S100 -LRB- Dako Cytomation , Ely , UK -RRB- , mouse anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- -LRB- anti-P75 -RRB- , rabbit antiserotonin -LRB- Chemicon -RRB- and goat anti-β-actin -LRB- Santa Cruz Biotechnology , Texas , USA -RRB- .	5670
Primary antibodies used in the present study were	5670
Primary antibodies	5670
the present study were	5697
the present study	5697
rabbit or mouse antineuronal class III beta tubulin -LRB- clone TUJ-1 , Covance , NJ , USA -RRB- , rabbit anti-GFAP or anti-S100 -LRB- Dako Cytomation , Ely , UK -RRB- , mouse anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- -LRB- anti-P75 -RRB- , rabbit antiserotonin -LRB- Chemicon -RRB- and goat anti-β-actin -LRB- Santa Cruz Biotechnology , Texas , USA -RRB-	5721
rabbit or mouse antineuronal class	5721
III beta tubulin -LRB- clone TUJ-1 , Covance , NJ , USA -RRB- , rabbit anti-GFAP or anti-S100 -LRB- Dako Cytomation , Ely , UK -RRB- , mouse anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- -LRB- anti-P75 -RRB- , rabbit antiserotonin -LRB- Chemicon -RRB- and goat anti-β-actin -LRB- Santa Cruz Biotechnology , Texas , USA -RRB-	5756
III beta tubulin -LRB- clone TUJ-1 , Covance , NJ , USA -RRB-	5756
III beta tubulin	5756
clone TUJ-1	5774
Covance	5787
NJ , USA	5796
rabbit anti-GFAP or anti-S100 -LRB- Dako Cytomation , Ely , UK -RRB-	5806
rabbit anti-GFAP or anti-S100	5806
Dako Cytomation	5837
Ely	5854
UK	5859
mouse anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- -LRB- anti-P75 -RRB-	5864
mouse anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB-	5864
mouse	5864
anti-low affinity nerve growth factor receptor -LRB- p75NGFR -RRB-	5870
anti-low affinity nerve growth factor receptor	5870
p75NGFR	5918
anti-P75	5927
rabbit antiserotonin -LRB- Chemicon -RRB-	5937
rabbit antiserotonin	5937
Chemicon	5959
goat anti-β-actin -LRB- Santa Cruz Biotechnology , Texas , USA -RRB-	5973
goat anti-β-actin	5973
Santa Cruz Biotechnology	5992
Texas	6018
USA	6025
all other chemicals	6056
Sigma-Aldrich Co.	6096
Cell culture and in vitro transduction The procedure to culture and purify OEC	6114
Cell culture and in vitro transduction The procedure to culture	6114
Cell culture and in vitro transduction	6114
Cell culture	6114
The procedure	6153
culture	6170
purify OEC	6182
the method described in Nash et al. , -LSB- 34 -RSB- with modification	6202
the method	6202
Nash et al. , -LSB- 34 -RSB-	6226
Nash et al.	6226
Nash	6226
et al.	6231
34 -RSB-	6240
modification	6249
the outer two layers of the adult Spraque-Dawley	6272
the outer two layers	6272
the adult Spraque-Dawley	6296
SD	6322
rat olfactory bulbs	6326
all meninges and blood vessels	6376
The tissues	6408
removal of trypsin	6467
removal	6467
trypsin	6478
the dissociated cells	6487
the	6487
cells	6503
uncoated dishes	6524
DMEM/F -12 -LRB- 1:1 mixture , Invitrogen -RRB- supplemented with 10 % FBS for 48 h -LRB- at 37 °C and 5 % CO2 -RRB-	6558
DMEM/F -12	6558
1:1 mixture	6569
Invitrogen	6582
10 % FBS for 48 h -LRB- at 37 °C and 5 % CO2 -RRB-	6612
10 % FBS	6612
48 h -LRB- at 37 °C and 5 % CO2 -RRB-	6624
48 h	6624
37 °C and 5 % CO2	6633
37 °C	6633
5 % CO2	6643
The suspended cells	6652
poly-D-lysine-coated dishes	6705
DMEM/F12 supplemented with 10 % FBS and astrocyteconditioned medium -LRB- ACM -RRB-	6751
DMEM/F12	6751
10 % FBS and astrocyteconditioned medium -LRB- ACM -RRB-	6778
10 % FBS	6778
astrocyteconditioned medium -LRB- ACM -RRB-	6790
astrocyteconditioned medium	6790
ACM	6819
Astrocytes	6825
our recent articles	6866
-LSB- 29 , 35 -RSB-	6886
ACM	6896
the released medium of confluent astrocytes after conditioning for 2 days	6920
the released medium	6920
confluent astrocytes after conditioning for 2 days	6943
confluent astrocytes	6943
conditioning for 2 days	6970
conditioning	6970
2 days	6987
OEC cultures	6995
fresh medium and ACM	7027
every 2 days	7048
they	7067
confluence	7080
Confluent OEC	7092
immunohistochemistry	7127
co-culture studies -LRB- by seeding to insert well -RRB-	7155
co-culture studies	7155
study	7215
confluent OEC	7222
AdGFP or AdPGIS 2	7255
AdGFP	7255
AdPGIS 2	7264
3 days	7273
activity	7312
eicosanoids	7335
AA	7352
transplantation	7362
SCI rats	7381
Neuronal cultures and OGD treatment Mixed neuron-glial cell cultures	7391
Neuronal cultures	7391
OGD treatment Mixed neuron-glial cell cultures	7413
the cortical or spinal cord regions of Spraque-Dawley -LRB- SD -RRB- rat fetus at gestation of 15 -- 17 days as described in Tsai et al. -LSB- 36 , 37 -RSB-	7479
the cortical or spinal cord regions of Spraque-Dawley -LRB- SD -RRB- rat fetus	7479
cortical or spinal cord regions of Spraque-Dawley -LRB- SD -RRB-	7483
cortical or spinal cord regions	7483
Spraque-Dawley	7518
SD	7534
gestation of 15	7551
gestation	7551
15	7564
17 days	7567
Tsai et al. -LSB- 36 , 37	7591
Tsai et al.	7591
Tsai	7591
et al.	7596
-LSB- 36 , 37	7603
cells	7622
mixtures of papain/protease/deoxyribonuclease I -LRB- 0.1 % : 0.1 % : 0.03 % -RRB-	7650
mixtures	7650
papain/protease/deoxyribonuclease I -LRB- 0.1 % : 0.1 % : 0.03 % -RRB-	7662
papain/protease/deoxyribonuclease I	7662
0.1 % : 0.1 % : 0.03 %	7699
0.1 %	7699
0.1 % : 0.03 %	7704
0.1 %	7704
0.03 %	7709
poly-D - lysine-coated dishes in DMEM supplemented with 10 % FBS	7732
poly-D	7732
lysine-coated dishes in DMEM supplemented with 10 % FBS	7740
lysine-coated dishes	7740
DMEM supplemented with 10 % FBS	7764
DMEM	7764
10 % FBS	7787
The cells	7796
37 °C in a water-saturated atmosphere of 5 % CO2/95 % air	7824
37 °C	7824
a water-saturated atmosphere of 5 % CO2/95 % air	7833
a water-saturated atmosphere	7833
5 % CO2/95 % air	7865
5 %	7865
CO2/95 %	7868
OGD treatment	7885
the culture media	7900
glucose-free DMEM	7937
an air-tight chamber	7971
0.5 %	8002
O2	8007
a gas mixture	8015
95 % N2/5 % CO2	8029
95 %	8029
N2/5 %	8033
3 h of OGD	8050
3 h	8050
OGD	8057
reperfusion	8062
the exposure medium	8101
normal growth medium	8126
Cultures	8148
none , OEC or AdPGIS-OEC	8184
0 h	8211
OGD reperfusion	8221
Two days later	8238
cultures	8254
propidium iodide -LRB- PI , 1 μg/ml -RRB- for 4 h	8281
propidium iodide -LRB- PI , 1 μg/ml -RRB-	8281
propidium iodide	8281
PI , 1 μg/ml	8299
PI	8299
1 μg/ml	8303
4 h	8316
fixation for immunohistochemistry	8327
fixation	8327
immunohistochemistry	8340
Images of immunoreactive -LRB- IR -RRB- or PI -LRB- + -RRB- cells were obtained under a fluorescent microscope	8362
Images	8362
immunoreactive -LRB- IR -RRB- or PI	8372
immunoreactive -LRB- IR -RRB-	8372
PI	8395
+	8399
a fluorescent microscope	8428
a cooling digital imaging system	8467
BetaIII tubulin-IR neurite density and PI -LRB- + -RRB- or	8501
BetaIII tubulin-IR neurite density	8501
PI -LRB- + -RRB- or	8540
PI -LRB- + -RRB-	8540
PI	8540
+	8544
+	8555
cell numbers -LRB- obtained using a 20x object lens -RRB- were analyzed using Image-Pro plus software -LRB- NIH systems , Bethesda , MD , USA -RRB-	8558
cell	8558
numbers -LRB- obtained using a 20x object lens -RRB-	8563
numbers	8563
a 20x object lens	8587
Image-Pro plus software -LRB- NIH systems , Bethesda , MD , USA -RRB-	8626
Image-Pro	8626
software -LRB- NIH systems , Bethesda , MD , USA -RRB-	8641
software	8641
NIH systems	8651
Bethesda	8664
MD , USA	8674
Recombinant adenovirus -LRB- Ad -RRB- Replication-defective first generation E1-deleted adenoviral vectors	8684
Recombinant adenovirus -LRB- Ad -RRB- Replication-defective first generation	8684
Recombinant adenovirus	8684
Ad	8708
Replication-defective first generation	8712
E1-deleted adenoviral vectors	8751
The recombinant adenoviruses	8792
phosphoglycerate kinase -LRB- PGK -RRB- as a driving promoter	8826
phosphoglycerate kinase -LRB- PGK -RRB-	8826
phosphoglycerate kinase	8826
PGK	8851
a driving promoter	8859
AdPGK -LRB- containing the promoter only without encoding gene -RRB-	8879
AdPGK	8879
the promoter	8897
gene	8932
a vector control	8950
AdGFP	8968
the infection conditions	9002
Large-scale production of high titer -LRB- ∼ 1010 pfu/mL -RRB- of adenovirus encoding none , GFP , or PGIS	9028
Large-scale production	9028
high titer	9054
∼ 1010 pfu/mL	9066
∼	9066
1010 pfu/mL	9067
adenovirus encoding none , GFP , or PGIS	9083
adenovirus	9083
none , GFP , or PGIS	9103
previous articles	9152
-LSB- 28 , 29 -RSB-	9170
AdGFP	9180
OEC culture	9199
a multiplicity of injection -LRB- MOI -RRB- of 50	9216
a multiplicity	9216
injection -LRB- MOI -RRB- of 50	9234
injection -LRB- MOI -RRB-	9234
injection	9234
MOI	9245
50	9253
transduction of virtually all cultured cells	9270
transduction	9270
virtually all cultured cells	9286
virtually all	9286
cells	9309
50 MOI each of recombinant Ads	9322
50 MOI each	9322
50 MOI	9322
each	9329
recombinant Ads	9337
infection	9366
OEC ex vivo	9388
OEC	9401
SCI rats at 2	9421
SCI rats	9421
2	9433
3 days	9435
AdPGK , AdGFP or AdPGIS	9468
ex vivo	9491
Extraction and analysis of arachidonic acid -LRB- AA -RRB- metabolites in cultured cells	9500
Extraction and analysis	9500
arachidonic acid -LRB- AA -RRB- metabolites in cultured cells	9527
arachidonic acid -LRB- AA -RRB- metabolites	9527
AA	9545
cultured cells	9564
OEC	9588
recombinant adenoviral infection	9598
2	9635
3 days	9639
their activity to synthesize eicosanoids from AA according to the methods described in our recent articles -LSB- 28 , 29 -RSB-	9663
eicosanoids	9692
AA	9709
the methods described in our recent articles -LSB- 28 , 29 -RSB-	9725
the methods	9725
our recent articles	9750
-LSB- 28 , 29 -RSB-	9770
confluent cells	9789
DMEM/F12 -LRB- serum-free -RRB- containing 10 μM -LSB- 1-14C -RSB- AA at 37 °C for 10 min	9823
10 μM -LSB- 1-14C -RSB- AA	9856
10 μM	9856
1-14C -RSB- AA	9863
37 °C for 10 min	9876
37 °C	9876
10 min	9886
The	9894
cells	9907
western blot analysis	9932
the media , containing released eicosanoids ,	9958
the media	9958
eicosanoids	9989
analysis of -LSB- 1-14C	10017
analysis	10017
-LSB- 1-14C	10029
AA metabolites	10045
The extracted -LSB- 1-14C -RSB- labeled AA metabolites were analyzed by reverse phase HPLC , a solvent delivery system -LRB- Waters model 2690 -RRB- equipped with an on-line radioisotopic detector -LRB- Packard 150-TP -RRB-	10061
The extracted -LSB- 1-14C	10061
AA metabolites	10091
reverse phase HPLC , a solvent delivery system -LRB- Waters model 2690 -RRB- equipped with an on-line radioisotopic detector -LRB- Packard 150-TP -RRB-	10123
reverse phase HPLC	10123
a solvent delivery system -LRB- Waters model 2690 -RRB- equipped with an on-line radioisotopic detector -LRB- Packard 150-TP -RRB-	10143
a solvent delivery system -LRB- Waters model 2690 -RRB-	10143
a solvent delivery system	10143
Waters model 2690	10170
an on-line radioisotopic detector -LRB- Packard 150-TP -RRB-	10203
an on-line radioisotopic detector	10203
Packard 150-TP	10238
methods described previously -LSB- 29 , 32 -RSB-	10263
methods	10263
-LSB- 29 , 32 -RSB-	10292
The -LSB- 1-14C -RSB- eicosanoids	10302
The -LSB- 1-14C	10302
eicosanoids	10314
their retention times	10345
the authentic radioisotopic standands	10372
Animal surgery and treatment Adult SD rats	10411
NYU Animal Breeding and Research Center in Taiwan	10469
NYU Animal Breeding and Research Center	10469
Taiwan	10512
the present study	10534
The surgical procedures for spinal cord transection and post-operative animal care	10553
The surgical procedures	10553
spinal cord transection and post-operative animal care	10581
spinal cord transection	10581
post-operative animal care	10609
the Institutional Animal Care and Use Committee -LRB- IACUC -RRB- of Taipei Veterans General Hospital and Reg	10670
the Institutional Animal Care and Use Committee -LRB- IACUC -RRB-	10670
the Institutional Animal Care and Use Committee	10670
IACUC	10719
Taipei Veterans General Hospital and Reg	10729
Taipei Veterans General Hospital	10729
Reg	10766
No 2014 -- 002 .	10771
No 2014	10771
002	10779
All efforts	10784
animal suffering	10819
surgery	10857
the numbers of animals that were sacrificed	10879
the numbers	10879
animals that were sacrificed	10894
animals	10894
Spinal cord transection surgery	10924
the previously described protocols -LSB- 36 , 38 , 39 -RSB-	10983
the previously	10983
protocols	11008
-LSB- 36 , 38 , 39 -RSB-	11018
rats	11041
1 -- 2 % isoflurane -LRB- Baxter , Guayama , PR , USA -RRB-	11069
1	11069
2 % isoflurane -LRB- Baxter , Guayama , PR , USA -RRB-	11073
2 % isoflurane	11073
Baxter	11088
Guayama	11096
PR , USA	11105
The body temperature	11115
surgery	11158
37 ± 0.5 °C	11169
37 ±	11169
0.5 °C	11174
a heating pad servo-controlled by a rectal probe	11186
a heating pad	11186
a rectal probe	11220
A laminectomy	11236
the thoracic vertebral level 8 -LRB- T8 -RRB-	11262
the thoracic vertebral level	11262
8 -LRB- T8 -RRB-	11291
The meningeal membranes	11299
the dura mater	11347
The spinal cord	11363
a 5 mm segment of spinal cord encompassing T8 being removed	11410
a 5 mm segment	11410
spinal cord encompassing T8 being removed	11428
spinal cord encompassing T8	11428
The rostral and caudal stumps	11471
The rostral	11471
caudal stumps	11487
removal of the spinal cord segment	11519
removal	11519
the spinal cord segment	11530
complete discontinuity	11564
cells	11601
a total of 5 × 105 OEC in fibrin solution ,	11608
a total	11608
5 ×	11619
105 OEC in fibrin solution	11622
105 OEC	11622
fibrin solution	11633
the transected cavity	11666
The muscle layers and the skins	11689
The muscle layers	11689
the skins	11711
Bladder evacuation	11745
experimental rats	11779
Behavior test for hindlimb performance	11810
Behavior test	11810
hindlimb performance	11828
transplantation	11879
3 months postgrafting	11899
3 months	11899
experimental rats	11922
anterograde tracing	11959
anterograde	11959
immunohistochemical staining	11986
Histological procedures Anterograde axonal tracing using WGA-horseradish peroxidase -LRB- HRP -RRB-	12016
Histological procedures	12016
Anterograde	12040
WGA-horseradish peroxidase	12073
HRP	12101
experimental rats at 12	12123
experimental rats	12123
12	12144
week	12147
surgery and transplantation	12158
WGA-HRP	12187
the hindlimb area of the sensory motor cortex -LRB- 10 sites , bilaterally , 0.3 μl/site -RRB- in experimental rats	12229
the hindlimb area	12229
the sensory motor cortex -LRB- 10 sites , bilaterally , 0.3 μl/site -RRB- in experimental rats	12250
the sensory motor cortex -LRB- 10 sites , bilaterally , 0.3 μl/site -RRB-	12250
the sensory motor cortex	12250
10 sites , bilaterally , 0.3 μl/site	12276
10 sites , bilaterally	12276
10 sites	12276
0.3 μl/site	12299
experimental rats	12315
anesthesia	12339
All injections	12351
a 3 min period	12386
the injection needle	12406
place for an additional 3 min	12439
place	12439
an additional 3 min	12449
leakage	12481
needle withdrawal	12492
the injection	12517
the muscles and skin	12532
the muscles	12532
skin	12548
layers	12568
Rats	12576
2 days	12603
tracer identification in spinal cords	12632
tracer identification	12632
spinal cords	12657
longitudinal sections -LRB- 14 μm -RRB- of thoracic spinal cord -LRB- T7 - T9 -RRB-	12680
longitudinal sections -LRB- 14 μm -RRB-	12680
longitudinal sections	12680
14 μm	12703
thoracic spinal cord -LRB- T7 - T9 -RRB-	12713
thoracic spinal cord	12713
T7 - T9	12735
T7	12735
T9	12739
tetramethylbenzidine -LRB- TMB -RRB- for HRP histochemistry	12763
tetramethylbenzidine -LRB- TMB -RRB-	12763
tetramethylbenzidine	12763
TMB	12785
HRP histochemistry	12794
TMB substrate kit -LRB- SK-4400 , Vector -RRB-	12826
TMB substrate kit	12826
SK-4400	12845
Vector	12854
immunohistochemical analysis	12867
rats	12897
phosphate-buffered 4 % paraformaldehyde at 3 or 12 weeks	12954
phosphate-buffered 4 % paraformaldehyde	12954
at 3 or 12 weeks	12993
transplanation	13016
The spinal segments	13032
4 % paraformaldehyde	13070
PBS	13127
30 % -LRB- w/v -RRB-	13142
30 %	13142
w/v	13147
sucrose for 3 days	13152
sucrose	13152
3 days	13164
The tissues	13172
Tissue TekOCT -LRB- Sakura Fine Technical , Tokyo , Japan -RRB-	13213
Tissue TekOCT	13213
Sakura Fine Technical	13228
Tokyo	13251
Japan	13258
20 μm thickness with a cryostat	13293
20 μm thickness	13293
a cryostat	13314
Immunohistochemical analysis Frozen spinal sections were processed for immunohistochemistry	13326
Immunohistochemical analysis	13326
Frozen spinal sections	13355
immunohistochemistry	13397
method described in our recent articles -LSB- 35 , 39 -RSB-	13427
method	13427
our recent articles	13447
-LSB- 35 , 39 -RSB-	13467
The tissue sections	13477
primary antibodies , followed by respective 2nd antibodies for histological evaluation as described	13517
primary antibodies	13517
respective 2nd antibodies for histological evaluation	13549
respective 2nd antibodies	13549
histological evaluation	13579
Primary antibodies used	13617
Primary antibodies	13617
: GFP -LRB- 1:200 , Millipore , Billerica , MA -RRB- , iba1 -LRB- 1:400 , Abcam , Cambridge , UK -RRB- , ED1 -LRB- 1:250 , AbD Serotec , UK -RRB- , GFAP -LRB- 1:400 ; DakoCytomation , Glostrup , Denmark -RRB- , S100 beta -LRB- 1:250 ; Sigma -RRB- , p75NGFR	13645
: GFP -LRB- 1:200 , Millipore , Billerica , MA -RRB- , iba1 -LRB- 1:400 , Abcam , Cambridge , UK -RRB- , ED1 -LRB- 1:250 , AbD Serotec , UK -RRB- , GFAP -LRB- 1:400 ; DakoCytomation , Glostrup , Denmark -RRB- , S100 beta -LRB- 1:250 ; Sigma -RRB-	13645
: GFP -LRB- 1:200 , Millipore , Billerica , MA -RRB- , iba1 -LRB- 1:400 , Abcam , Cambridge , UK -RRB- , ED1 -LRB- 1:250 , AbD Serotec , UK -RRB-	13645
GFP -LRB- 1:200 , Millipore , Billerica , MA -RRB-	13647
GFP	13647
1:200	13652
Millipore	13659
Billerica , MA	13670
iba1 -LRB- 1:400 , Abcam , Cambridge , UK -RRB- , ED1 -LRB- 1:250 , AbD Serotec , UK -RRB-	13686
iba1	13686
1:400	13691
Abcam	13698
Cambridge , UK	13705
ED1 -LRB- 1:250 , AbD Serotec , UK -RRB-	13721
ED1	13721
1:250	13726
AbD Serotec	13733
UK	13746
GFAP -LRB- 1:400 ; DakoCytomation , Glostrup , Denmark -RRB- , S100 beta -LRB- 1:250 ; Sigma -RRB-	13751
GFAP -LRB- 1:400 ; DakoCytomation , Glostrup , Denmark -RRB- , S100 beta	13751
GFAP	13751
1:400 ; DakoCytomation , Glostrup , Denmark	13757
1:400	13757
DakoCytomation , Glostrup , Denmark	13764
S100 beta	13798
1:250 ; Sigma	13809
1:250	13809
Sigma	13816
p75NGFR	13824
+	13832
-LRB- 1:500 ; Millipore , Billerica , MA -RRB- and type III beta tubulin -LRB- 1:250 ; Covance Research Products Inc. , Denver , PA -RRB-	13835
-LRB- 1:500 ; Millipore , Billerica , MA -RRB-	13835
1:500	13836
Millipore , Billerica , MA	13843
Millipore	13843
Billerica	13854
MA	13865
type III beta tubulin -LRB- 1:250 ; Covance Research Products Inc. , Denver , PA -RRB-	13873
type III beta tubulin	13873
1:250 ;	13896
1:250	13896
Covance Research Products Inc. , Denver , PA	13903
Covance Research Products Inc.	13903
Denver , PA	13935
Denver	13935
PA	13943
double immunostaining	13952
the secondary antibodies used	13975
the secondary antibodies	13975
Alex 488 fluorophore donkey anti-rabbit antibody -LRB- 1:200 ; Molecular Probes , Eugene , OR , USA -RRB- and Cy3-conjugated donkey anti-mouse antibody -LRB- 1:200 ; Jackson ImmunoResearch Laboratories , West Grove , PA -RRB-	14010
Alex 488 fluorophore donkey anti-rabbit antibody -LRB- 1:200 ; Molecular Probes , Eugene , OR , USA -RRB-	14010
Alex 488 fluorophore	14010
donkey anti-rabbit antibody -LRB- 1:200 ; Molecular Probes , Eugene , OR , USA -RRB-	14031
donkey anti-rabbit antibody	14031
1:200	14060
Molecular Probes , Eugene , OR , USA	14067
Molecular Probes	14067
Eugene	14085
OR	14093
USA	14097
Cy3-conjugated donkey anti-mouse antibody -LRB- 1:200 ; Jackson ImmunoResearch Laboratories , West Grove , PA -RRB-	14106
Cy3-conjugated donkey	14106
anti-mouse antibody -LRB- 1:200 ; Jackson ImmunoResearch Laboratories , West Grove , PA -RRB-	14128
anti-mouse antibody	14128
1:200 ; Jackson ImmunoResearch Laboratories	14149
1:200	14149
Jackson ImmunoResearch Laboratories	14156
West Grove , PA	14193
West Grove	14193
PA	14205
Primary antibody omission controls	14210
all immunostaining protocols	14264
nonspecific binding	14308
Fluorescent visualization and photography	14329
Fluorescent visualization	14329
photography	14359
a Zeiss Axioscope microscope	14389
appropriate filter sets -LRB- Zeiss , Oberkochen , Germany -RRB-	14423
appropriate filter sets	14423
Zeiss	14448
Oberkochen	14455
Germany	14467
Behavioral assessment Hindlimb performance	14477
the open field locomotor test initially developed by Basso et al. -LSB- 40 -RSB- as described in our recent articles -LSB- 36 , 39 -RSB-	14540
the open field locomotor test	14540
Basso et al. -LSB- 40 -RSB- as described in our recent articles -LSB- 36 , 39 -RSB-	14593
Basso et al. -LSB-	14593
40 -RSB-	14607
our recent articles	14627
-LSB- 36 , 39	14647
Two observers , unaware of the experimental procedures ,	14657
Two observers	14657
the experimental procedures	14683
the test	14722
the Basso Beattie Bresnahan -LRB- BBB -RRB- open field locomotor test and Combined Behavior Score -LRB- CBS -RRB- scales	14753
the Basso Beattie Bresnahan -LRB- BBB -RRB- open field	14753
Basso Beattie Bresnahan -LRB- BBB -RRB-	14757
Basso Beattie Bresnahan	14757
BBB	14782
locomotor test	14798
Behavior Score -LRB- CBS -RRB- scales	14826
The BBB scale	14855
0 -LRB- no hindlimb movement -RRB-	14881
0	14881
no hindlimb movement	14884
21 -LRB- normal movement-coordinated gait -RRB- -LSB- 40 -RSB-	14909
21 -LRB- normal movement-coordinated gait -RRB-	14909
21	14909
normal movement-coordinated gait	14913
40 -RSB-	14948
Western blot analysis After experimental periods , cultured cells	14953
Western blot analysis	14953
experimental periods , cultured cells	14981
experimental periods	14981
cells	15012
PBS	15041
lysis buffer containing 40 mM Tris buffer -LRB- pH 7.5 -RRB- , 8 M urea , 4 % CHAPS , 1 mM PMSF , 1 mM Na3VO4 , 1 mM dithiothreitol , and a protease inhibitor kit -LRB- BM , Germany -RRB-	15064
lysis buffer	15064
40 mM Tris buffer -LRB- pH 7.5 -RRB- , 8 M urea , 4 % CHAPS , 1 mM PMSF , 1 mM Na3VO4 , 1 mM dithiothreitol , and a protease inhibitor kit -LRB- BM , Germany -RRB-	15088
40 mM Tris buffer -LRB- pH 7.5 -RRB-	15088
40 mM	15088
Tris buffer -LRB- pH 7.5 -RRB-	15094
Tris buffer	15094
pH 7.5	15107
8 M urea , 4 % CHAPS , 1 mM PMSF , 1 mM Na3VO4 , 1 mM dithiothreitol , and a protease inhibitor kit -LRB- BM , Germany -RRB-	15116
8 M urea	15116
4 % CHAPS	15126
1 mM PMSF , 1 mM Na3VO4 , 1 mM dithiothreitol	15136
1 mM PMSF	15136
1 mM Na3VO4	15147
1 mM dithiothreitol	15160
a protease inhibitor kit -LRB- BM , Germany -RRB-	15185
a protease inhibitor kit	15185
BM	15211
Germany	15215
Protein	15225
a Biorad protein assay reagent	15251
Aliquots of proteins -LRB- 5 μg -RRB- of the cell lysates	15283
Aliquots	15283
proteins -LRB- 5 μg -RRB- of the cell lysates	15295
proteins -LRB- 5 μg -RRB-	15295
proteins	15295
5 μg	15305
the cell lysates	15314
western blot , using SDS-PAGE -LRB- 8 % or 12 % gel -RRB- , as previously described -LSB- 35 , 41 -RSB-	15348
western blot	15348
SDS-PAGE -LRB- 8 % or 12 % gel -RRB- , as previously described -LSB- 35 , 41	15368
SDS-PAGE -LRB- 8 % or 12 % gel -RRB-	15368
SDS-PAGE	15368
8 % or 12 % gel	15378
8 %	15378
12 % gel	15384
-LSB- 35 , 41	15418
electrophoresis	15434
gels	15451
PVDF membranes -LRB- Millipore Corp. , USA -RRB-	15476
PVDF membranes	15476
Millipore Corp.	15492
USA	15509
overnight at 4 °C	15528
overnight	15528
4 °C	15541
antibodies against PGIS -LRB- rabbit , dilution 1/3000 -RRB- , COX-1 , COX-2 -LRB- rabbit , dilution 1/5000 , Cayman -RRB- or β-actin -LRB- 1:5000 ; Santa Cruz Biotech , USA -RRB-	15551
antibodies	15551
PGIS -LRB- rabbit , dilution 1/3000 -RRB- , COX-1 , COX-2 -LRB- rabbit , dilution 1/5000 , Cayman -RRB- or β-actin -LRB- 1:5000 ; Santa Cruz Biotech , USA -RRB-	15570
PGIS -LRB- rabbit , dilution 1/3000 -RRB-	15570
PGIS	15570
rabbit	15576
dilution 1/3000	15584
COX-1	15602
COX-2 -LRB- rabbit , dilution 1/5000 , Cayman -RRB-	15609
COX-2	15609
rabbit	15616
dilution 1/5000	15624
Cayman	15641
β-actin -LRB- 1:5000 ; Santa Cruz Biotech , USA -RRB-	15652
β-actin	15652
1:5000 ; Santa Cruz Biotech , USA	15661
1:5000	15661
Santa Cruz Biotech , USA	15669
a HRP-conjugated secondary antibody -LRB- dilution 1/2000 , Jackson Lab -RRB- for 1 h at room temperature	15706
a HRP-conjugated secondary antibody -LRB- dilution 1/2000 , Jackson Lab -RRB-	15706
a HRP-conjugated secondary antibody	15706
dilution 1/2000	15743
Jackson Lab	15760
1 h at room temperature	15777
1 h	15777
room temperature	15784
Immunoreactivity	15802
enhanced chemiluminescent detection -LRB- Perkin Elmer Co , USA -RRB-	15837
enhanced chemiluminescent detection	15837
Perkin Elmer Co	15874
USA	15891
Statistical analysis Experimental data	15897
the mean of independent values	15954
the mean	15954
independent values	15966
s.e.m.	15987
one-way analysis of variance -LRB- ANOVA -RRB- followed by LSD test	16018
one-way analysis	16018
variance -LRB- ANOVA -RRB- followed by LSD test	16038
variance	16038
ANOVA	16048
LSD test	16067
Values of P < 0.05	16077
Values	16077
P < 0.05	16087
P	16087
< 0.05	16089
<	16089
0.05	16091
statistical significance	16120
Results Table 1 Results of animal behavior , neuronal tracing of WGA-HRP and 5-TH immunoreactivity at 12 weeks after injury and treatment A few 5HT -LRB- + -RRB- fibers were found in the distal stump , within 1 mm distal to the transected gap , in one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats Anterograde tracing	16147
Results	16147
Table 1	16155
Results of animal behavior , neuronal tracing of WGA-HRP and 5-TH immunoreactivity at 12 weeks after injury and treatment A few 5HT -LRB- + -RRB- fibers were found in the distal stump , within 1 mm distal to the transected gap , in one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats Anterograde tracing	16163
Results of animal behavior	16163
Results	16163
animal behavior	16174
neuronal tracing of WGA-HRP and 5-TH immunoreactivity at 12 weeks after injury and treatment A few 5HT -LRB- + -RRB- fibers were found in the distal stump , within 1 mm distal to the transected gap , in one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats Anterograde tracing	16191
neuronal tracing of WGA-HRP and 5-TH immunoreactivity at 12 weeks after injury and treatment A few 5HT -LRB- + -RRB- fibers were found in the distal stump , within 1 mm distal to the transected gap , in one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats Anterograde	16191
WGA-HRP and 5-TH immunoreactivity at 12 weeks after injury and treatment	16211
WGA-HRP and 5-TH immunoreactivity	16211
12 weeks after injury and treatment	16248
12 weeks	16248
injury and treatment	16263
A few 5HT -LRB- + -RRB- fibers were found in the distal stump , within 1 mm distal to the transected gap , in one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats	16284
A few 5HT	16284
+	16295
the distal stump	16319
1 mm distal to the transected gap	16344
1 mm	16344
the transected gap	16359
one Tx + OEC Tp and three Tx + AdPGIS-OEC Tp rats	16382
one Tx + OEC Tp	16382
one Tx	16382
OEC Tp	16391
three Tx + AdPGIS-OEC Tp rats	16402
three Tx	16402
AdPGIS-OEC Tp rats	16413
motor cortex in experimental rats	16471
motor cortex	16471
experimental rats	16487
WGA -LRB- + -RRB- fibers were found in the thoracic level 12 in two Tx + AdPGIS-OEC Tp rats .	16506
WGA	16506
+	16511
the thoracic level 12 in two Tx + AdPGIS-OEC Tp rats	16535
the thoracic level 12	16535
two Tx + AdPGIS-OEC Tp rats	16560
two Tx	16560
AdPGIS-OEC Tp rats	16569
T12 , no WGA	16635
T12	16635
no WGA	16640
+	16648
signals were found in the motor cortex of SCI rats -LRB- one rat per group -RRB- Fig. 1 Characterization of cultured olfactory ensheathing cells -LRB- OEC -RRB-	16651
signals	16651
the motor cortex of SCI rats -LRB- one rat per group -RRB-	16673
the motor cortex	16673
SCI rats -LRB- one rat per group -RRB-	16693
SCI rats	16693
one rat per group	16703
one rat	16703
group	16715
Fig. 1 Characterization of cultured olfactory ensheathing cells -LRB- OEC -RRB-	16723
Fig. 1 Characterization	16723
olfactory ensheathing cells -LRB- OEC -RRB-	16759
olfactory ensheathing cells	16759
OEC	16788
low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- immunoreactivity of OEC , -LRB- b -RRB- : S100 immunoreactivity of OEC , -LRB- c -RRB- : GFAP immunoreactivity of OEC , -LRB- d -RRB- : OEC expressing GFP at 3 days after Ad-GFP infection	16797
low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- immunoreactivity of OEC , -LRB- b -RRB- : S100 immunoreactivity of OEC , -LRB- c -RRB- : GFAP immunoreactivity of OEC	16797
low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- immunoreactivity of OEC , -LRB- b -RRB- : S100 immunoreactivity of OEC , -LRB- c -RRB-	16797
low affinity nerve growth factor receptor -LRB- p75NGFR -RRB- immunoreactivity	16797
OEC , -LRB- b -RRB- : S100 immunoreactivity of OEC , -LRB- c -RRB-	16869
OEC , -LRB- b -RRB- : S100 immunoreactivity of OEC ,	16869
OEC	16869
-LRB- b -RRB- : S100 immunoreactivity of OEC	16874
: S100 immunoreactivity	16877
OEC	16904
c	16910
GFAP immunoreactivity of OEC	16914
GFAP immunoreactivity	16914
OEC	16939
-LRB- d -RRB- : OEC expressing GFP at 3 days after Ad-GFP infection	16944
OEC expressing GFP at 3 days after Ad-GFP infection	16949
OEC	16949
GFP	16964
3 days after Ad-GFP infection	16971
3 days	16971
Ad-GFP infection	16984
+	17010
cells 90.8 ± 4 % ; S100 -LRB- + -RRB- cells , 91.3 ± 2.9 % ; weak GFAP -LRB- + -RRB- cells , 97.0 ± 1.3 %	17013
cells 90.8 ± 4 % ; S100 -LRB- + -RRB- cells , 91.3 ± 2.9 % ; weak GFAP -LRB- + -RRB- cells	17013
cells	17013
90.8	17019
4 % ;	17026
4	17026
%	17027
+	17035
cells , 91.3 ± 2.9 % ; weak GFAP -LRB- + -RRB- cells	17038
cells , 91.3 ± 2.9 % ; weak GFAP	17038
cells	17038
91.3 ± 2.9 % ; weak GFAP	17045
91.3 ± 2.9 %	17045
91.3	17045
2.9 %	17052
weak GFAP	17058
cells	17072
97.0 ± 1.3 %	17079
97.0	17079
1.3 %	17086
Nuclei	17092
Hoechst 33258 -LRB- blue -RRB-	17123
Hoechst 33258	17123
blue	17138
Bar	17145
50 μm	17151
Data	17158
average ± SD	17180
the results of two independent experiments performed in triplicate -LRB- n = 6 per experimental conditions -RRB-	17207
the results	17207
two independent experiments performed in triplicate -LRB- n = 6 per experimental conditions -RRB-	17222
two independent experiments	17222
triplicate -LRB- n = 6 per experimental conditions -RRB-	17263
triplicate	17263
n = 6 per experimental conditions	17275
n = 6	17275
n	17275
6	17279
experimental conditions	17285
that OEC	17316
Ad-GFP infection Fig. 2 The enzyme activity and respective protein expression of eicosanoid biosynthesis	17350
Ad-GFP infection Fig. 2 The enzyme activity	17350
Ad-GFP infection Fig. 2	17350
Ad-GFP infection Fig.	17350
2	17373
The enzyme activity	17375
respective protein expression of eicosanoid biosynthesis	17399
respective protein expression	17399
eicosanoid biosynthesis	17432
OEC	17468
a & b : HPLC analysis of 14C-labelled eicosanoids generated in Control and AdPGIS-transduced OEC cultures , respectively , in response to -LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB- .	17473
a & b	17473
a	17473
b	17477
HPLC analysis of 14C-labelled eicosanoids generated in Control and AdPGIS-transduced OEC cultures , respectively , in response to -LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB-	17480
HPLC analysis	17480
14C-labelled eicosanoids generated in Control and AdPGIS-transduced OEC cultures , respectively , in response to -LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB-	17497
14C-labelled eicosanoids	17497
Control and AdPGIS-transduced OEC cultures	17535
response to -LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB-	17596
response	17596
-LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB-	17608
-LSB- 1-14C -RSB- arachidonic acid	17608
-LSB- 1-14C -RSB-	17608
AA	17634
6-keto-PGF1α , the product of PGI2 hydrolysis	17652
6-keto-PGF1α	17652
the product of PGI2 hydrolysis	17666
the product	17666
PGI2 hydrolysis	17681
Each prostanoid peak	17698
coelution with an authentic radiolabelled prostanoid , c : Western blot analysis of protein levels of PGIS , COX-1 and COX-2	17735
coelution	17735
an authentic radiolabelled prostanoid , c : Western blot analysis of protein levels of PGIS , COX-1 and COX-2	17750
an authentic radiolabelled prostanoid	17750
c : Western blot analysis of protein levels of PGIS , COX-1 and COX-2	17789
c	17789
Western blot analysis of protein levels of PGIS , COX-1 and COX-2	17792
Western blot analysis	17792
protein levels of PGIS , COX-1 and COX-2	17817
protein levels	17817
PGIS , COX-1 and COX-2	17835
OEC receiving AdPGK or AdPGIS infection	17869
OEC	17869
AdPGK or AdPGIS infection	17883
Measurement of eicosanoid biosynthesis and biosynthetic enzyme expression in cultures	17910
Measurement	17910
eicosanoid biosynthesis and biosynthetic enzyme expression in cultures	17925
eicosanoid biosynthesis and biosynthetic enzyme expression	17925
cultures	17987
3 days	18013
Ads transduction	18026
Confluent OEC cultures	18044
-LSB- 1-14C -RSB- AA for 10 min	18084
-LSB- 1-14C -RSB- AA	18084
-LSB- 1-14C -RSB-	18084
10 min	18099
The released -LSB- 1-14C -RSB- eicosanoids in the released medium of OEC	18107
The released -LSB- 1-14C -RSB- eicosanoids	18107
1-14C -RSB-	18121
the released medium of OEC	18143
the released medium	18143
OEC	18166
HPLC with a radiochemical flowthrough detector	18213
HPLC	18213
a radiochemical flowthrough detector	18223
that OEC	18266
COX-1 and COX-2 but not PGIS	18300
COX-1 and COX-2	18300
PGIS	18324
Ad-PGIS infection	18333
PGIS expression	18352
AA metabolites in OEC	18386
AA metabolites	18386
OEC	18404
6-ketoPGF1α -LRB- 6-KP -RRB- synthesis Fig. 3 OEC co-cultures protected OGD-induced cell damage in mixed neuron-glial cultures	18429
6-ketoPGF1α -LRB- 6-KP -RRB-	18429
6-ketoPGF1α	18429
6-KP	18442
synthesis Fig. 3 OEC co-cultures	18448
OGD-induced cell damage	18492
mixed neuron-glial cultures	18519
a & d : neuron-glial cultures , -LRB- b & e -RRB- : Con-OEC cocultured with neuron-glial culture , -LRB- c & f -RRB- : PGIS-OEC cocultured with neuron-glial cultures , -LRB- g -RRB- : quantitative bar chart for tubulin-IR density , -LRB- h -RRB- : quantitative bar chart for PI	18548
& d : neuron-glial cultures , -LRB- b & e -RRB- : Con-OEC cocultured with neuron-glial culture , -LRB- c & f -RRB- : PGIS-OEC cocultured with neuron-glial cultures , -LRB- g -RRB- : quantitative bar chart for tubulin-IR density , -LRB- h -RRB- : quantitative bar chart for PI	18550
& d : neuron-glial cultures , -LRB- b & e -RRB-	18550
& d	18550
neuron-glial cultures , -LRB- b & e -RRB-	18555
neuron-glial	18555
cultures	18568
b & e	18579
Con-OEC cocultured with neuron-glial culture , -LRB- c & f -RRB- : PGIS-OEC cocultured with neuron-glial cultures , -LRB- g -RRB- : quantitative bar chart for tubulin-IR density , -LRB- h -RRB- : quantitative bar chart for PI	18587
Con-OEC cocultured with neuron-glial culture , -LRB- c & f -RRB-	18587
Con-OEC	18587
neuron-glial culture , -LRB- c & f -RRB-	18611
neuron-glial culture	18611
c & f	18634
c	18634
f	18638
PGIS-OEC cocultured with neuron-glial cultures , -LRB- g -RRB-	18642
PGIS-OEC	18642
neuron-glial cultures , -LRB- g -RRB-	18667
neuron-glial cultures	18667
g	18691
quantitative bar chart for tubulin-IR density , -LRB- h -RRB-	18695
quantitative bar chart	18695
tubulin-IR density , -LRB- h -RRB-	18722
tubulin-IR density	18722
h	18743
quantitative bar chart for PI	18747
quantitative bar chart	18747
PI	18774
cell numbers in neuron-glial cultures	18781
cell numbers	18781
neuron-glial cultures	18797
a-c	18820
tubulin immunoreactive cells , -LRB- d-f -RRB- are PI -LRB- + -RRB- cells	18828
tubulin	18828
immunoreactive cells , -LRB- d-f -RRB-	18836
immunoreactive cells	18836
-LRB- + -RRB- cells	18871
+	18872
Bar	18882
100 μm	18888
P <	18901
P	18901
<	18903
0.01,0.05 , compared to neuron-glial cultures	18905
0.01,0.05	18905
neuron-glial cultures	18928
One-way analysis of variance + Bonferroni post test .	18951
One-way analysis	18951
variance + Bonferroni post test	18971
variance	18971
Data	19004
mean ± SEM	19027
the results of three	19049
the results	19049
three	19064
independent experiments -LRB- n = 8-10 per experimental conditions -RRB- Fig. 4 PGIS-overexpressing OEC cocultures enhanced neuronal connection and reduced microglial number in spinal cord neuron-glial cultures	19070
independent experiments	19070
n = 8-10 per experimental conditions	19095
n = 8-10	19095
n	19095
8-10	19098
experimental conditions	19107
Fig. 4 PGIS-overexpressing OEC cocultures enhanced neuronal connection and reduced microglial number in spinal cord neuron-glial cultures	19133
Fig.	19133
4 PGIS-overexpressing OEC cocultures	19138
neuronal connection	19184
microglial number in spinal cord	19216
microglial number	19216
spinal cord	19237
neuron-glial cultures	19249
a & d	19273
a	19273
d	19277
neuron-glial cultures only , -LRB- b & e -RRB- : neuron-glial cultures cocultured with Con-OEC , -LRB- c & f -RRB- : neuron-glial cultures cocultured with PGISOEC , -LRB- g & h -RRB- : quantitative bar charts for tubulin immunoreactivity and ED1	19281
neuron-glial cultures only , -LRB- b & e -RRB- : neuron-glial cultures cocultured with Con-OEC , -LRB- c & f -RRB- : neuron-glial cultures cocultured with PGISOEC , -LRB- g & h -RRB-	19281
neuron-glial cultures only , -LRB- b & e -RRB-	19281
neuron-glial	19281
cultures only , -LRB- b & e -RRB-	19294
cultures only	19294
cultures	19294
b & e	19310
neuron-glial cultures cocultured with Con-OEC , -LRB- c & f -RRB- : neuron-glial cultures cocultured with PGISOEC , -LRB- g & h -RRB-	19318
neuron-glial cultures	19318
Con-OEC , -LRB- c & f -RRB-	19356
Con-OEC	19356
c & f	19366
c	19366
f	19370
neuron-glial cultures cocultured with PGISOEC , -LRB- g & h -RRB-	19374
neuron-glial cultures	19374
PGISOEC , -LRB- g & h -RRB-	19412
PGISOEC	19412
g & h	19422
g	19422
h	19426
quantitative bar charts for tubulin immunoreactivity and ED1	19430
quantitative bar charts	19430
tubulin immunoreactivity and ED1	19458
cell numbers , respectively	19495
cell numbers	19495
A-C	19523
immunoreactive cells	19539
D-F	19564
-LRB- + -RRB- microglial cells	19576
+	19577
Bar	19598
100 μm	19604
P <	19617
P	19617
<	19619
0.01,0.05 , compared to neuron-glial cultures , by one-way analysis of variance + Bonferroni post test	19621
0.01,0.05	19621
neuron-glial cultures	19644
one-way analysis of variance + Bonferroni post test	19670
one-way analysis	19670
variance + Bonferroni post test	19690
variance	19690
Data	19723
mean ± SEM	19746
the results of two independent experiments performed in duplicate-triplicate Fig.	19768
the results	19768
two independent experiments performed in duplicate-triplicate Fig.	19783
two independent experiments	19783
duplicate-triplicate Fig.	19824
5 Spinal cord transection injury and transplantation of OEC a : Scheme showing segments of thoracic spinal cord -LRB- T7 ~ T9 ; R : rostral ; C : caudal -RRB-	19851
5 Spinal cord transection injury and transplantation of OEC a	19851
5 Spinal cord transection	19851
injury and transplantation of OEC a	19877
injury and transplantation	19877
OEC a	19907
Scheme showing segments of thoracic spinal cord -LRB- T7 ~ T9 ; R : rostral ; C : caudal -RRB-	19914
Scheme	19914
segments of thoracic spinal cord -LRB- T7 ~ T9 ; R : rostral ; C : caudal -RRB-	19929
segments	19929
thoracic spinal cord -LRB- T7 ~ T9 ; R : rostral ; C : caudal -RRB-	19941
thoracic spinal cord	19941
T7 ~ T9	19963
T7	19963
~ T9	19966
R : rostral ; C : caudal	19972
R	19972
rostral ; C	19975
rostral	19975
C	19984
caudal	19987
The location of GFP expressing OEC	19996
The location	19996
GFP expressing OEC	20012
GFP	20012
OEC	20027
EDF	20045
Complete transection injury -LRB- with a 5 mm gap -RRB- in thoracic spinal cord	20053
Complete transection injury -LRB- with a 5 mm gap -RRB-	20053
Complete transection injury	20053
a 5 mm gap	20087
thoracic spinal cord	20102
c : Transplantation of fibrin glue-mixed OEC	20124
c	20124
Transplantation of fibrin glue-mixed OEC	20127
Transplantation	20127
fibrin glue-mixed OEC	20146
the transection cavity	20171
d-f GFP-expressing OEC in the transection cavity of spinal cord	20195
d-f GFP-expressing OEC	20195
the transection cavity of spinal cord	20221
the transection cavity	20221
spinal cord	20247
1 week posttransplantation	20262
d Higher magnification of GFP -LRB- + -RRB- OEC .	20290
d	20290
Higher magnification of GFP -LRB- + -RRB- OEC	20292
Higher magnification of GFP -LRB- + -RRB-	20292
Higher magnification	20292
GFP	20316
+	20321
OEC	20324
Bar	20329
150 μm in d , 50 μm in e & f. g-i GFP-expressing OEC in the spinal stumps of 3 week SCI rats at 4 -- 5 mm rostral or caudal	20335
150 μm in d , 50 μm in e	20335
150 μm	20335
d , 50 μm in e	20345
d	20345
50 μm in e	20348
50 μm	20348
f. g-i GFP-expressing OEC in the spinal stumps of 3 week SCI rats at 4	20359
f. g-i	20359
GFP-expressing OEC in the spinal stumps of 3 week SCI rats at 4	20366
GFP-expressing OEC	20366
the spinal stumps of 3 week SCI rats at 4	20388
the spinal stumps	20388
3 week SCI rats at 4	20409
3 week SCI rats	20409
4	20428
5 mm rostral or caudal	20430
5 mm rostral	20430
caudal	20446
the lesion epicenter	20456
Bar	20478
50 μm	20484
Adult OEC	20491
GFP	20523
adenovirus - mediated gene transfer before transplantation	20530
adenovirus	20530
gene transfer	20551
transplantation	20572
one week post-transplanation	20598
GFP -LRB- + -RRB- OEC were found in the transected cavity -LRB- in d -RRB- and in regions close to both spinal stumps -LRB- marked with star in e & f -RRB-	20628
GFP	20628
+	20633
the transected cavity -LRB- in d -RRB-	20654
the transected cavity	20654
d	20680
regions close to both spinal stumps -LRB- marked with star in e & f -RRB-	20690
regions close to both spinal stumps	20690
regions	20690
both spinal stumps	20707
star in e	20739
star	20739
& f	20749
3 weeks postgraft	20758
+	20782
both stumps	20801
4	20816
5 mm	20818
rotstral or caudal to the lesion epicenter	20823
rotstral or caudal	20823
the lesion epicenter	20845
AdGFP-OEC	20875
GFP persistently in the host spinal cord for at least 3 weeks Fig.	20911
the host spinal cord for at least 3 weeks	20931
the host spinal cord	20931
at least 3 weeks	20956
6 Iba1-immunoreative microglial cells in the spinal cords of SCI rats at 3 weeks postinjury	20979
6 Iba1-immunoreative microglial cells	20979
the spinal cords of SCI rats at 3 weeks postinjury	21020
the spinal cords	21020
SCI rats at 3 weeks postinjury	21040
SCI rats	21040
3 weeks postinjury	21052
a & b : rostral stump ; c & d :	21072
a & b : rostral stump	21072
& b : rostral	21074
& b	21074
c & d	21094
c	21094
d	21098
gap	21112
&	21119
caudal stumps	21124
a , c , e : GFP-OEC-grafted spinal cords ; b , d , f : PGIS-OEC-grafted spinal cords .	21139
a , c ,	21139
a	21139
c	21142
GFP-OEC-grafted spinal cords ; b , d , f : PGIS-OEC-grafted spinal cords	21148
GFP-OEC-grafted spinal cords	21148
b	21178
d , f : PGIS-OEC-grafted spinal cords	21181
d , f	21181
d	21181
f	21184
PGIS-OEC-grafted spinal cords	21187
Green label	21218
Iba1 positive microglia	21236
g	21261
The histograms	21264
the percentage of Iba1-positive microglia in the spinal cords of SCI rats Fig. 7 Improving hindlimb locomotor functions	21284
the percentage	21284
Iba1-positive microglia in the spinal cords of SCI rats Fig. 7 Improving hindlimb locomotor functions	21302
Iba1-positive microglia	21302
the spinal cords	21329
SCI rats	21349
SCI rats	21408
OEC or AdPGIS-OEC transplant	21427
transection spinal cord injury	21462
a & b : BBB scores , expressed as line chart and scatter plot , respectively , of SCI rats receiving none , OEC graft or AdPGIS-OEC graft , -LRB- c -RRB- : CBS score of SCI rats receiving none , OEC graft or AdPGIS-OEC graft .	21494
a & b	21494
a	21494
b	21498
BBB scores , expressed as line chart and scatter plot , respectively , of SCI rats receiving none , OEC graft or AdPGIS-OEC graft , -LRB- c -RRB-	21501
BBB scores	21501
line chart and scatter plot , respectively , of SCI rats	21526
line chart and scatter plot , respectively ,	21526
line chart and scatter plot	21526
SCI rats	21572
none , OEC graft or AdPGIS-OEC graft , -LRB- c -RRB-	21591
none , OEC graft or AdPGIS-OEC graft ,	21591
none	21591
OEC graft or AdPGIS-OEC graft	21597
c	21629
CBS score of SCI rats receiving none , OEC graft or AdPGIS-OEC graft	21633
CBS score	21633
SCI rats	21646
none , OEC graft or AdPGIS-OEC graft	21665
none	21665
OEC graft	21671
AdPGIS-OEC graft	21684
OEC transplant	21702
functional recovery	21725
a complete transection	21751
spinal cord	21777
Scatter plot showing the BBB score for the control -LRB- TX -RRB- and transplant animals at 12 weeks after the transplantation of OEC .	21790
Scatter plot	21790
the BBB score for the control -LRB- TX -RRB- and transplant animals at 12 weeks	21811
the BBB score for the control -LRB- TX -RRB-	21811
the BBB score	21811
the control -LRB- TX -RRB-	21829
the control	21829
TX	21842
transplant animals at 12 weeks	21850
transplant animals	21850
12 weeks	21872
the transplantation of OEC	21887
the transplantation	21887
OEC	21910
a , P < 0.05 Tx + OEC Tp versus Tx only ; b , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx only ; c , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx + OEC Tp 。	21915
a , P	21915
a	21915
P	21918
< 0.05 Tx + OEC Tp versus Tx only ; b , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx only ; c , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx + OEC Tp 。	21920
< 0.05 Tx	21920
<	21920
0.05 Tx	21922
OEC Tp versus Tx only ; b , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx only ; c , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx + OEC Tp 。	21932
OEC Tp versus Tx only	21932
OEC Tp	21932
Tx only	21946
b , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx only	21954
b	21954
P < 0.05 Tx + AdPGIS-OEC Tp versus Tx only	21957
P < 0.05 Tx	21957
P <	21957
P	21957
0.05 Tx	21961
AdPGIS-OEC Tp versus Tx only	21971
AdPGIS-OEC Tp	21971
Tx only	21992
c , P < 0.05 Tx + AdPGIS-OEC Tp versus Tx + OEC Tp 。	22001
c	22001
P < 0.05 Tx + AdPGIS-OEC Tp versus Tx + OEC Tp 。	22004
P < 0.05 Tx	22004
P <	22004
P	22004
0.05 Tx	22008
AdPGIS-OEC Tp versus Tx + OEC Tp 。	22017
AdPGIS-OEC Tp versus Tx	22017
AdPGIS-OEC Tp	22017
Tx	22038
OEC Tp 。	22043
OEC Tp	22043
。	22049
Data	22050
ANOVA followed by LSD test	22072
ANOVA	22072
LSD test	22090
Data	22100
the mean ± SEM Fig. 8 Serotonin immunoreactive nerve fibers and WGA-HRP labelled signals were detected in the proximal and distal stumps of AdPGIS-transduced OEC-transplanted spinal cords	22115
the mean ± SEM Fig.	22115
8 Serotonin immunoreactive nerve fibers and WGA-HRP labelled signals	22136
8 Serotonin immunoreactive nerve fibers and WGA-HRP	22136
signals	22197
the proximal and distal stumps of AdPGIS-transduced OEC-transplanted spinal cords	22222
the proximal and distal stumps	22222
AdPGIS-transduced OEC-transplanted spinal cords	22256
a-c : Serotonin immunoreactivity in the longitudinal section of spinal cord .	22305
a-c	22305
Serotonin immunoreactivity in the longitudinal section of spinal cord	22310
Serotonin immunoreactivity	22310
the longitudinal section of spinal cord	22340
the longitudinal section	22340
spinal cord	22368
Bar	22381
50 μm	22387
d & e : WGA-HRP labelled signals with TMB positive staining in the proximal and distal spinal cords , respectively , of animals	22394
d	22394
&	22396
WGA-HRP	22401
signals	22418
TMB positive staining in the proximal and distal spinal cords , respectively , of animals	22431
TMB positive staining	22431
the proximal and distal spinal cords , respectively ,	22456
the proximal and distal spinal cords	22456
animals	22511
AdPGIS-OEC using anterograde WGA-HRP tracing from motor sensory cortex	22532
AdPGIS-OEC	22532
anterograde WGA-HRP tracing from motor sensory cortex	22549
anterograde WGA-HRP	22549
motor sensory cortex	22582
Bar	22604
100 μm	22610
a and b	22618
a	22618
b	22624
longitudinal sections of proximal cord	22630
longitudinal sections	22630
proximal cord	22655
The dotted line	22670
the separation between grey and white matter in panel a. Arrow indicate 5-HT -LRB- + -RRB- fibers	22695
the separation between grey and white matter in panel a. Arrow indicate 5-HT	22695
the separation	22695
grey and white matter in panel a. Arrow indicate 5-HT	22718
grey and white matter	22718
panel a.	22743
Arrow	22752
5-HT	22767
fibers	22775
c	22783
the 5-HT -LRB- + -RRB- fibers in the gray matter of OEC-transplanted distal cords -LRB- longitudinal section -RRB-	22791
the 5-HT -LRB- + -RRB- fibers in the gray matter of OEC-transplanted distal cords	22791
the	22791
+	22800
fibers in the gray matter of OEC-transplanted distal cords	22803
fibers	22803
the gray matter of OEC-transplanted distal cords	22813
longitudinal section	22863
Inset : higher magnification of boxed inset in -LRB- c -RRB- .	22886
Inset	22886
higher magnification of boxed inset in -LRB- c -RRB-	22893
higher magnification	22893
boxed inset in -LRB- c -RRB-	22917
boxed inset in	22917
c	22933
d	22937
transverse sections of T7 -LRB- proximal -RRB- and T12 -LRB- distal -RRB-	22949
transverse sections	22949
T7 -LRB- proximal -RRB- and T12 -LRB- distal -RRB-	22972
T7	22972
T12	22990
stumps	23003
We	23025
OEC culture	23058
adult rat olfactory bulb	23075
confluence	23116
OEC	23128
immunocytochemistry	23167
Histologic analysis of cultured OEC	23188
Histologic analysis	23188
cultured OEC	23211
> 90 % of cells	23238
> 90 %	23238
>	23238
cells	23246
low affinity nerve growth factor receptor -LRB- p75 -RRB- , S100 and GFAP -LRB- Fig. 1a-c , 90.8 ± 4 % , 91.3 ± 2.9 % , 97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells -RRB-	23275
low affinity nerve growth factor receptor	23275
p75	23318
S100	23324
GFAP -LRB- Fig. 1a-c , 90.8 ± 4 % , 91.3 ± 2.9 % , 97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells -RRB-	23333
GFAP	23333
Fig. 1a-c , 90.8 ± 4 % , 91.3 ± 2.9 % , 97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells	23339
Fig. 1a-c	23339
90.8 ± 4 % , 91.3 ± 2.9 % , 97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells	23350
90.8 ± 4 %	23350
90.8	23350
4 %	23357
91.3 ± 2.9 % , 97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells	23361
91.3 ± 2.9 %	23361
91.3	23361
2.9 %	23368
97.0 ± 1.3 % , respectively , compared to Hoechst 33258 -LRB- + -RRB- cells	23374
97.0 ± 1.3 %	23374
97.0	23374
1.3 %	23381
Hoechst 33258 -LRB- + -RRB- cells	23413
Hoechst 33258 -LRB- + -RRB-	23413
Hoechst 33258	23413
+	23427
cells	23430
The infective tropism of recombinant adenovirus in OEC	23438
The infective tropism	23438
recombinant adenovirus in OEC	23463
recombinant adenovirus	23463
OEC	23489
AdGFP infection	23508
AdGFP	23525
OEC culture	23544
50 MOI , resulting in transduction of virtually all cultured cells -LRB- Fig. 1d -RRB-	23561
50 MOI	23561
transduction of virtually all cultured cells -LRB- Fig. 1d -RRB-	23582
transduction	23582
virtually all cultured cells -LRB- Fig. 1d -RRB-	23598
virtually all	23598
cells -LRB- Fig. 1d -RRB-	23621
cells	23621
Fig. 1d	23628
This	23638
OEC	23658
AdGFP infection	23687
Our pilot study	23704
the expressional existence of COX-1 and COX-2 , but not PGIS , in cultured OEC	23733
the expressional existence of COX-1 and COX-2	23733
the expressional existence	23733
COX-1 and COX-2	23763
PGIS , in cultured OEC	23788
PGIS	23788
OEC	23806
recombinant AdPGIS	23817
OEC for selective eicosanoid production	23866
OEC	23866
selective eicosanoid production	23874
Recombinant AdPGK	23907
a -LRB- mock -RRB- vector control	23937
mock	23940
2 -- 3 days after AdPGK or AdPGIS infection	23965
2	23965
3 days after AdPGK or AdPGIS infection	23967
3 days	23967
AdPGK or AdPGIS infection	23980
the biosynthetic activity of eicosanoid in confluent OEC cultures	24007
the biosynthetic activity	24007
eicosanoid in confluent OEC cultures	24036
eicosanoid	24036
confluent OEC cultures	24050
Fig. 2a & b	24087
Fig. 2a	24087
b	24097
the HPLC spectrum of 14C-labelled eicosanoid production	24105
the HPLC spectrum	24105
14C-labelled eicosanoid production	24126
cultured OEC in response	24164
cultured OEC	24164
response	24180
-LSB- 1-14C -RSB- arachidonic acid -LRB- AA -RRB- treatment	24192
-LSB- 1-14C -RSB-	24192
AA	24218
There	24233
two predominant peaks , 14C-labelled prostaglandin -LRB- PG -RRB- E2 and AA in nontreated OEC cultures -LRB- Fig. 2a -RRB-	24244
two predominant peaks	24244
14C-labelled prostaglandin -LRB- PG -RRB- E2	24267
14C-labelled prostaglandin	24267
PG	24295
E2	24299
AA in nontreated OEC cultures -LRB- Fig. 2a -RRB-	24306
AA	24306
nontreated OEC cultures -LRB- Fig. 2a -RRB-	24312
nontreated OEC cultures	24312
Fig. 2a	24337
Very small peak of prostacyclin , shown as its hydrolysis product 6-keto - PGF1α -LRB- 6KP -RRB- ,	24347
Very small peak	24347
prostacyclin	24366
its hydrolysis product 6-keto - PGF1α -LRB- 6KP -RRB-	24389
its hydrolysis product 6-keto	24389
PGF1α	24420
6KP	24427
OEC	24451
The transduction of AdPGK in cultured OEC	24456
The transduction	24456
AdPGK in cultured OEC	24476
AdPGK	24476
cultured OEC	24485
the metabolic profile of -LSB- 1-14C -RSB- AA -LRB- data not shown -RRB-	24512
the metabolic profile	24512
-LSB- 1-14C -RSB- AA -LRB- data not shown -RRB-	24537
-LSB- 1-14C -RSB- AA	24537
-LSB- 1-14C -RSB-	24537
data not shown	24549
data	24549
AA metabolites	24581
prostacyclin synthesis on AdPGIS transduction	24617
prostacyclin synthesis	24617
AdPGIS transduction	24643
OEC	24666
An increased 6KP level with a concurrent decrease of PGE2 level	24671
An increased 6KP level	24671
a concurrent decrease of PGE2 level	24699
a concurrent decrease	24699
PGE2 level	24724
AdPGIStransduced OEC cultures -LRB- Fig. 2b -RRB-	24755
AdPGIStransduced OEC cultures	24755
Fig. 2b	24786
This	24796
the overexpressing PGIS in OEC	24816
the overexpressing PGIS	24816
OEC	24843
prostacyclin	24884
AA	24902
Western blot analysis of OEC further	24906
Western blot analysis	24906
OEC further	24931
OEC	24957
high levels of COX-1 and COX-2 but not PGIS	24971
high levels of COX-1 and COX-2	24971
high levels	24971
COX-1 and COX-2	24986
PGIS	25010
AdPGIS infection	25019
expression of PGIS	25037
expression	25037
PGIS	25051
Fig. 2c	25071
Beneficial effect of OEC or PGIS-overexpressing OEC -LRB- PGIS-OEC -RRB-	25081
Beneficial effect	25081
OEC or PGIS-overexpressing OEC -LRB- PGIS-OEC -RRB-	25102
OEC or PGIS-overexpressing OEC	25102
PGIS-OEC	25134
co-culture of OEC	25166
co-culture	25166
OEC	25180
cortical neuron-glial cultures	25189
treatment with OGD , an in vitro ischemia	25226
treatment	25226
OGD , an in vitro ischemia	25241
OGD	25241
an in vitro ischemia	25246
ischemia	25258
Neuron-glial cultures	25268
3 h of OGD stress	25300
3 h	25300
OGD stress	25307
normoxic condition	25334
OEC or PGIS-OEC -LRB- seeded in Millicell insert well -RRB-	25354
OEC or PGIS-OEC	25354
Millicell insert	25381
these stressed neuron-glial culture and further incubated for 2 days	25428
these stressed neuron-glial culture	25428
further incubated for 2 days	25468
further	25468
2 days	25490
Fig. 3a-c	25498
the stressed neurons	25519
tubulin-IR	25581
both OEC and PGIS-OEC co-cultures	25596
neuron-glial cultures only	25643
neuron-glial cultures	25643
The relative density of tubulin-IR in both co-cultures	25671
The relative density	25671
tubulin-IR	25695
co-cultures	25714
those in neuron-glial cultures only -LRB- Fig. 3g ; P < 0.01 -RRB-	25757
those in neuron-glial cultures only	25757
those	25757
neuron-glial cultures	25766
Fig. 3g ; P < 0.01	25794
Fig. 3g	25794
P < 0.01	25803
P <	25803
P	25803
0.01	25807
the neuronal densities between these two OEC-treated groups	25823
the neuronal densities	25823
these two OEC-treated groups	25854
no difference -LRB- Fig. 3g -RRB-	25888
no difference	25888
Fig. 3g	25903
PI -LRB- + -RRB- cells in both OEC co-culture groups were significantly less than those	25927
PI	25927
+	25931
cells	25934
both OEC co-culture	25943
groups	25963
those	25999
neuron-glial cultures only -LRB- Fig. 3d-f and h ; P < 0.01 or 0.05 -RRB-	26008
neuron-glial cultures only	26008
neuron-glial cultures	26008
Fig. 3d-f and h ; P < 0.01 or 0.05	26036
Fig. 3d-f and h	26036
P < 0.01 or 0.05	26053
P	26053
< 0.01 or 0.05	26055
<	26055
This result	26072
OEC cocultures	26099
neuronal cells	26136
OGD-induced damage	26156
We	26176
the effect of OEC or PGIS-OEC insert on neuron or microglia	26193
the effect of OEC	26193
the effect	26193
OEC	26207
PGIS-OEC insert on neuron or microglia	26214
PGIS-OEC insert	26214
neuron or microglia	26233
spinal cord neuron-glial cultures	26256
spinal cord	26256
neuron-glial cultures	26268
Fig. 4a-c & g	26303
Fig. 4a-c	26303
g	26315
neuronal connection -LRB- tubulin - IR density -RRB-	26318
neuronal connection	26318
tubulin - IR density	26339
tubulin	26339
IR density	26348
PGIS-OEC cocultures	26388
that in neuron-glial cultures only or its co-culture with OEC -LRB- P < 0.05 or 0.01 -RRB-	26421
that in neuron-glial cultures only	26421
that	26421
neuron-glial cultures only	26429
neuron-glial cultures	26429
its co-culture with OEC -LRB- P < 0.05 or 0.01 -RRB-	26459
its co-culture	26459
OEC -LRB- P < 0.05 or 0.01 -RRB-	26479
OEC	26479
P < 0.05 or 0.01	26484
P	26484
< 0.05 or 0.01	26486
<	26486
contrast	26506
ED1-IR-microglial number in neuron-glial cultures	26516
ED1-IR-microglial number	26516
neuron-glial cultures	26544
PGIS-OEC co-cultures	26595
that in neuron-glial cultures only or by OEC co-culture -LRB- P < 0.01 -RRB- -LRB- Fig. 4d-f & h -RRB-	26629
that	26629
neuron-glial cultures	26637
OEC co-culture -LRB- P < 0.01 -RRB- -LRB- Fig. 4d-f & h -RRB-	26670
OEC co-culture -LRB- P < 0.01 -RRB-	26670
OEC co-culture	26670
P < 0.01	26686
P	26686
< 0.01	26688
<	26688
0.01	26690
Fig. 4d-f & h	26697
Fig. 4d-f	26697
h	26709
The in vivo growth-promoting properties of OEC or PGIS-OEC	26713
The in vivo growth-promoting properties of OEC	26713
growth-promoting properties of OEC	26725
growth-promoting properties	26725
OEC	26756
PGIS-OEC	26763
transplantation of each OEC	26793
transplantation	26793
each OEC	26812
the complete T8-transected cavities of rat spinal cords	26824
the complete T8-transected cavities	26824
rat spinal cords	26863
Adult OEC	26881
GFP or PGIS	26916
adenovirus-mediated gene transfer	26931
AdPGISinfected OEC in fibrin solution	26976
AdPGISinfected OEC	26976
fibrin solution	26998
the transected cavity -LRB- 5 mm gap -RRB- of spinal cord	27035
the transected cavity -LRB- 5 mm gap -RRB-	27035
the transected cavity	27035
5 mm gap	27058
spinal cord	27071
thoracic level 8 , as shown in Fig. 5a-c	27086
thoracic level 8	27086
Fig. 5a-c	27116
Figure .	27127
5b	27135
a complete transection of T8	27144
a complete transection	27144
T8	27170
a 5 mm gap	27178
Fig. 5c	27190
fibrin-mixed OEC	27204
the transected T8 gap	27236
the	27236
T8 gap	27251
OEC graft in vivo	27268
OEC graft	27268
vivo	27281
the AdGFP-infected OEC transplanted SCI rats	27287
the AdGFP-infected OEC	27287
SCI rats	27323
the first , third , fifth , eighth and twelfth week after surgery	27364
the first , third , fifth , eighth and twelfth week	27364
surgery	27419
Fig. 5d-f	27428
GFPimmunoreactive OEC	27444
the longitudinal spinal section -LRB- T7 ~ T9 -RRB- of AdGFP-infected OEC grafted SCI rats	27469
the longitudinal spinal section -LRB- T7 ~ T9 -RRB-	27469
the longitudinal spinal section	27469
T7 ~ T9	27502
AdGFP-infected OEC grafted SCI rats	27514
AdGFP-infected OEC	27514
SCI rats	27541
one week postgraft	27554
+	27579
the transected cavity -LRB- Fig. 5d -RRB-	27600
the transected cavity	27600
Fig. 5d	27623
regions close to both spinal stumps -LRB- marked with stars in Fig. 5e & f -RRB-	27639
regions close to both spinal stumps	27639
regions	27639
both spinal stumps	27656
stars in Fig. 5e & f	27688
stars	27688
Fig. 5e & f	27697
Fig. 5e	27697
f	27707
the cells	27715
the rostral/caudal stumps of the spinal cord	27746
the rostral/caudal stumps	27746
the spinal cord	27775
We	27792
any	27810
+	27819
OEC in the grafted site at third weeks post-graft onwards in SCI rats	27822
OEC	27822
the grafted site at third weeks post-graft onwards in SCI rats	27829
the grafted site	27829
third weeks post-graft onwards in SCI rats	27849
third weeks	27849
post-graft onwards in SCI rats	27861
post-graft onwards	27861
SCI rats	27883
OEC	27901
spinal cord stumps	27924
GFP -LRB- + -RRB- OEC was	27957
GFP	27957
+	27962
both rostral/caudal stumps of the spinal cord about 4 -- 5 mm	27982
rostral/caudal stumps of the spinal cord about 4	27987
rostral/caudal stumps	27987
the spinal cord about 4	28012
the spinal cord	28012
4	28034
5 mm	28036
the injured epicenter at third weeks post-graft -LRB- Fig. 5g-i -RRB-	28051
the injured epicenter at third weeks post-graft	28051
the injured epicenter at third weeks	28051
the injured epicenter	28051
third weeks	28076
Fig. 5g-i	28100
the effects of prostacyclin	28123
the effects	28123
prostacyclin	28138
inflammatory cells	28154
Iba1-immunoreactive microglia in the 3 week injured spinal cords of the AdGFP-OEC-grafted and AdPGIS-OEC-grafted groups	28174
Iba1-immunoreactive microglia	28174
the 3 week injured spinal cords of the AdGFP-OEC-grafted and AdPGIS-OEC-grafted groups	28207
the 3 week	28207
spinal cords of the AdGFP-OEC-grafted and AdPGIS-OEC-grafted groups	28226
spinal cords	28226
the AdGFP-OEC-grafted and AdPGIS-OEC-grafted groups	28242
the AdGFP-OEC-grafted	28242
AdPGIS-OEC-grafted groups	28268
Fig. 6 Iba1 immunoreactivity	28321
the rostral/caudal stumps of two groups	28372
the rostral/caudal stumps	28372
two groups	28401
relative few Iba1 immunoreactivity	28421
the transection gap	28469
Microglial cells in the rostral/caudal stumps of AdPGIS-OEC grafted spinal cords	28490
Microglial cells	28490
the rostral/caudal stumps of AdPGIS-OEC grafted spinal cords	28510
the rostral/caudal stumps	28510
AdPGIS-OEC grafted spinal cords	28539
AdPGIS-OEC	28539
spinal cords	28558
less immunoreactivity	28576
that of AdGFP-OEC grafted spinal cords	28603
that	28603
AdGFP-OEC grafted spinal cords	28611
AdGFP-OEC	28611
spinal cords	28629
transected gap	28654
microglial cells	28670
similar immunocreactivity between AdPGIS-OEC-grafted and AdGFP-OEC-grafted spinal cords	28692
similar immunocreactivity	28692
AdPGIS-OEC-grafted and AdGFP-OEC-grafted spinal cords	28726
AdPGIS-OEC-grafted	28726
AdGFP-OEC-grafted spinal cords	28749
all experimental rats receiving similar degrees of injury	28791
all experimental rats	28791
similar degrees of injury	28823
similar degrees	28823
injury	28842
the rate of their recovery	28864
the rate	28864
their recovery	28876
the rats	28892
locomotor functional assessment by BBB and CBS scores	28928
locomotor functional assessment	28928
BBB and CBS scores	28963
Fig. 7a	28995
OEC transplant	29004
functional recovery	29027
rats	29050
a complete transection injury in spinal cord	29061
a complete transection injury	29061
spinal cord	29094
The BBB scores of the SCI rats receiving OEC and AdPGIS-OEC	29107
The BBB scores	29107
the SCI rats receiving OEC and AdPGIS-OEC	29125
the SCI rats	29125
OEC and AdPGIS-OEC	29148
that in SCI rats	29184
that	29184
SCI rats	29192
vehicle treatment -LRB- BBB scores 2 -- 5 -RRB-	29206
vehicle treatment	29206
BBB scores 2 -- 5	29225
BBB scores	29225
2 -- 5	29236
The values	29243
those observed in SCI rats with vehicle treatment -LRB- BBB scores < 1 -RRB-	29288
those	29288
SCI rats	29306
vehicle treatment -LRB- BBB scores < 1 -RRB-	29320
vehicle treatment	29320
BBB scores < 1	29339
BBB scores	29339
< 1	29350
<	29350
1	29351
The BBB scores in vehicle-treated rats	29355
The BBB scores	29355
vehicle-treated rats	29373
those shown by our previous studies -LSB- 1 , 2 , 39 -RSB-	29410
those	29410
our previous studies	29425
-LSB- 1 , 2 , 39 -RSB-	29446
6 weeks through 12 weeks	29472
6 weeks	29472
12 weeks	29488
post-graft , OEC or AdPGIS-OEC treatment	29497
the hindlimb function of SCI rats -LRB- all P < 0.05 -RRB-	29560
the hindlimb function	29560
SCI rats -LRB- all P < 0.05 -RRB-	29585
SCI rats	29585
all P < 0.05	29595
all P <	29595
0.05	29603
The BBB scores of OEC or AdPGIS-OEC	29610
The BBB scores	29610
OEC or AdPGIS-OEC	29628
each other until 12 week post graft -LRB- P < 0.05 -RRB-	29670
each other until 12 week post graft	29670
12 week	29687
P < 0.05	29707
P	29707
< 0.05	29709
<	29709
0.05	29711
The locomotion in SCI rats receiving AdPGIS-OEC	29718
The locomotion	29718
SCI rats receiving AdPGIS-OEC	29736
SCI rats	29736
AdPGIS-OEC	29755
12 week post SCI with significant increase of BBB score -LRB- BBB : 5.2 ± 0.7 , Fig. 7a -RRB- over that in OEC graft only -LRB- BBB : 3.4 ± 0.5 -RRB-	29782
12 week post SCI	29782
significant increase of BBB score -LRB- BBB : 5.2 ± 0.7 , Fig. 7a -RRB- over that in OEC graft only -LRB- BBB : 3.4 ± 0.5 -RRB-	29804
significant increase	29804
BBB score -LRB- BBB : 5.2 ± 0.7 , Fig. 7a -RRB- over that in OEC graft only -LRB- BBB : 3.4 ± 0.5 -RRB-	29828
BBB score -LRB- BBB : 5.2 ± 0.7 , Fig. 7a -RRB-	29828
BBB score	29828
BBB : 5.2 ± 0.7 , Fig. 7a	29839
BBB : 5.2 ± 0.7	29839
BBB	29839
5.2	29843
0.7	29849
Fig. 7a	29854
that in OEC graft only -LRB- BBB : 3.4 ± 0.5 -RRB-	29868
that in OEC graft only	29868
that	29868
OEC graft	29876
BBB : 3.4 ± 0.5	29892
BBB	29892
3.4 ± 0.5	29896
3.4	29896
0.5	29902
Fig. 7b	29908
the scatter plot of BBB scores of each SCI rat	29924
the scatter plot	29924
BBB scores of each SCI rat	29944
BBB scores	29944
each SCI rat	29958
none , OEC graft or AdPGIS-OEC graft	29981
none	29981
OEC graft	29987
AdPGIS-OEC graft	30000
12 weeks post treatment	30020
Fig. 7c	30045
CBS scores of these experimental rats	30059
CBS scores	30059
these experimental rats	30073
non-treated group	30110
the experimental groups that received OEC or AdPGISOEC transplantation	30129
the experimental groups	30129
OEC or AdPGISOEC transplantation	30167
better restoration	30209
SCI rats with OEC or AdPGIS-OEC grafts	30229
SCI rats	30229
OEC or AdPGIS-OEC grafts	30243
improvement -LRB- significantly lower CBS score -RRB-	30277
improvement	30277
CBS score	30310
combined behavior function than vehicle-treated SCI rats -LRB- P < 0.05 -RRB-	30324
combined behavior function	30324
vehicle-treated SCI rats -LRB- P < 0.05 -RRB-	30356
vehicle-treated SCI rats	30356
P < 0.05	30382
P	30382
< 0.05	30384
<	30384
0.05	30386
10 & 12 week postgraft	30396
10	30396
12 week postgraft	30401
the CBS of AdPGIS-OEC grafted SCI rats	30420
the CBS	30420
AdPGIS-OEC grafted SCI rats	30431
AdPGIS-OEC	30431
SCI rats	30450
that of OEC grafted SCI rats -LRB- P < 0.05 -RRB-	30493
that	30493
OEC grafted SCI rats -LRB- P < 0.05 -RRB-	30501
OEC	30501
SCI rats -LRB- P < 0.05 -RRB-	30513
SCI rats	30513
P < 0.05	30523
P	30523
< 0.05	30525
<	30525
0.05	30527
none of the animals	30543
none	30543
the animals	30551
movements of fore and hind limbs or the ability	30588
movements	30588
fore and hind limbs or the ability	30601
fore and hind limbs	30601
the ability	30624
weight	30644
the hind limbs	30654
12 weeks post injury and treatment	30673
12 weeks	30673
rats	30709
histological analysis or anterograde	30732
histological analysis	30732
anterograde	30757
neural regeneration	30791
Fig. 8a-b	30812
typical serotonin immunoreactive fibers in the proximal stump of OEC - or AdPGIS-OEC-grafted spinal cord	30828
typical serotonin immunoreactive fibers in the proximal stump of OEC	30828
typical serotonin immunoreactive fibers	30828
the proximal stump of OEC	30871
the proximal stump	30871
OEC	30893
AdPGIS-OEC-grafted spinal cord	30901
Fig. 8c	30933
a few	30947
5-HT fibers	30966
the distal stump of OEC-grafted spinal cord	30981
the distal stump	30981
OEC-grafted spinal cord	31001
Such serotonergic axons in the distal cord	31026
Such serotonergic axons	31026
the distal cord	31053
one	31086
six OECtransplanted SCI rats -LRB- 16.7 % -RRB-	31097
six OECtransplanted SCI rats	31097
16.7 %	31127
three	31138
five AdPGIS-OEC transplanted SCI rats -LRB- 60 % -RRB-	31151
five AdPGIS-OEC	31151
SCI rats -LRB- 60 % -RRB-	31180
SCI rats	31180
60 %	31190
the WGA anterograde	31206
results	31234
Fig. 8d	31243
the	31264
+	31273
staining fibers of corticospinal tract in the -LRB- intact , thoracic T7 -RRB- proximal stump of AdPGISOEC - grafted spinal cord	31276
staining fibers	31276
corticospinal tract in the -LRB- intact , thoracic T7 -RRB- proximal stump of AdPGISOEC - grafted spinal cord	31295
corticospinal tract	31295
the -LRB- intact , thoracic T7 -RRB- proximal stump	31318
intact	31323
thoracic T7	31331
AdPGISOEC - grafted spinal cord	31362
AdPGISOEC	31362
spinal cord	31381
A few regenerating TMB -LRB- + -RRB- staining -LRB- arrow -RRB- fibers were found in the distal stump -LRB- at thoracic T12 ; Fig. 8e -RRB- of two out of six AdPGIS-OECgraft SCI rats -LRB- 40 % -RRB- .	31394
A few	31394
TMB -LRB- + -RRB- staining -LRB- arrow -RRB- fibers were found in the distal stump -LRB- at thoracic T12 ; Fig. 8e -RRB- of two out of six AdPGIS-OECgraft SCI rats -LRB- 40 % -RRB-	31413
TMB	31413
+	31418
staining	31421
-LRB- arrow -RRB- fibers	31430
-LRB- arrow -RRB-	31430
fibers	31438
the distal stump -LRB- at thoracic T12 ; Fig. 8e -RRB- of two out of six	31459
the distal stump -LRB- at thoracic T12 ; Fig. 8e -RRB-	31459
the distal stump	31459
thoracic T12 ; Fig. 8e	31480
thoracic T12	31480
Fig. 8e	31494
two	31506
six	31517
AdPGIS-OECgraft SCI rats -LRB- 40 % -RRB-	31521
AdPGIS-OECgraft SCI rats	31521
40 %	31547
Nothing	31553
the distal stump of transected SCI rats	31579
the distal stump	31579
transected SCI rats	31599
Table 1	31620
the corresponding results of animal behavior , neuronal tracing of WGA-HRP and serotonin immunoreactivity at 12 weeks after injury and treatment	31636
the corresponding results	31636
animal behavior , neuronal tracing of WGA-HRP and serotonin immunoreactivity at 12 weeks after injury and treatment	31665
animal behavior	31665
neuronal tracing of WGA-HRP and serotonin immunoreactivity at 12 weeks after injury and treatment	31682
neuronal	31682
WGA-HRP and serotonin immunoreactivity	31702
12 weeks after injury and treatment	31744
12 weeks	31744
injury and treatment	31759
Discussion The central observation of this study is that overexpression of prostacyclin synthetase in OEC mediated through Ad gene transfer	31781
Discussion	31781
The central observation of this study	31792
The central observation	31792
this study	31819
overexpression of prostacyclin synthetase in OEC	31838
overexpression	31838
prostacyclin synthetase in OEC	31856
prostacyclin synthetase	31856
OEC	31883
Ad gene transfer	31904
prostacyclin synthesis	31942
other eicosanoid levels	31990
This PGIS overexpressing OEC	32015
good neuroregenerative potential in cortical or spinal neuron-glial cultures	32048
good neuroregenerative potential	32048
cortical or spinal neuron-glial cultures	32084
Further in vivo studies	32126
vivo	32137
transplantation of OEC to the injured site in SCI rats	32162
transplantation	32162
OEC to the injured site in SCI rats	32181
OEC	32181
the injured site in SCI rats	32188
the injured site	32188
SCI rats	32208
axonal regeneration	32229
a 5 mm transection gap	32256
hindlimb function	32292
Transplantation of AdPGIS-transduced OEC to T8-transected rats	32311
Transplantation	32311
AdPGIS-transduced OEC to T8-transected rats	32330
AdPGIS-transduced OEC	32330
T8-transected rats	32355
fiber tract regeneration	32391
the functional outcome	32443
We	32467
evidence of axonal regeneration	32481
evidence	32481
axonal regeneration	32493
a complete spinal cord transection in 40 % of AdPGIS-OEC spinal rats	32520
a complete spinal cord transection	32520
40 % of AdPGIS-OEC spinal rats	32558
40 %	32558
AdPGIS-OEC spinal rats	32565
anterograde WGA	32591
motor sensory cortex	32620
serotonergic axons	32655
the distal cord	32677
one of OEC-transplanted rats -LRB- 16.7 % -RRB- and three of AdPGIS-OEC transplanted rats -LRB- 60 % -RRB-	32715
one of OEC-transplanted rats -LRB- 16.7 % -RRB-	32715
one	32715
OEC-transplanted rats -LRB- 16.7 % -RRB-	32722
OEC-transplanted rats	32722
16.7 %	32745
three of AdPGIS-OEC transplanted rats -LRB- 60 % -RRB-	32756
three	32756
AdPGIS-OEC transplanted rats -LRB- 60 % -RRB-	32765
AdPGIS-OEC transplanted rats	32765
60 %	32795
Nothing	32801
the transected SCI rats	32822
We	32847
adult OEC cultures	32867
their unique seeding properties	32889
plastic dish	32924
More than 90 % of these cells	32938
More than 90 %	32938
these cells	32955
S100 and p75 , the low affinity nerve growth receptor	32990
S100 and p75	32990
the low affinity nerve growth receptor	33004
This	33044
the reported characteristic of OEC , a specialized glia with both Schwann cell-like and astrocyte-like properties	33068
the reported characteristic	33068
OEC , a specialized glia with both Schwann cell-like and astrocyte-like properties	33099
OEC	33099
a specialized glia with both Schwann cell-like and astrocyte-like properties	33104
a specialized glia	33104
both Schwann cell-like and astrocyte-like properties	33128
Schwann cell-like	33133
Schwann	33133
cell-like	33141
astrocyte-like properties	33155
-LSB- 17 , 34 , 42 -RSB-	33181
We	33195
OEC	33226
exogenous arachidonic acid	33251
PGE2 , a COX-1 - or COX-2 - derived product	33283
PGE2	33283
a COX-1 - or COX-2 - derived product	33289
a COX-1 - or COX-2 -	33289
a COX-1	33289
COX-2	33301
product	33316
The high AA metabolic activity of OEC	33325
The high AA metabolic activity	33325
OEC	33359
that of astrocytes reported in our recent article -LSB- 29 -RSB-	33383
that	33383
astrocytes reported in our recent article -LSB- 29 -RSB-	33391
astrocytes	33391
our recent article -LSB- 29 -RSB-	33414
our recent article	33414
29 -RSB-	33434
this	33448
contrast	33459
low AA metabolic activity in neuron-glial cells , which released barely detected eicosanoids -LSB- 28 -RSB-	33471
low AA metabolic activity	33471
neuron-glial cells , which released barely detected eicosanoids -LSB- 28 -RSB-	33500
neuron-glial cells	33500
eicosanoids -LSB- 28 -RSB-	33551
eicosanoids	33551
28 -RSB-	33564
gene transfer of AdPGIS to OEC	33584
gene transfer	33584
AdPGIS to OEC	33601
AdPGIS	33601
OEC	33611
the AA catabolism	33623
synthesis of 6	33649
synthesis	33649
6	33662
keto-PGF1α , a hydrolyzed product of prostacyclin and the production of other eicosanoids	33665
keto-PGF1α	33665
a hydrolyzed product of prostacyclin and the production of other eicosanoids	33677
a hydrolyzed product of prostacyclin	33677
a hydrolyzed product	33677
prostacyclin	33701
the production of other eicosanoids	33718
the production	33718
other eicosanoids	33736
Fig. 2	33780
This	33789
the overexpressing PGIS	33809
cooperation	33860
endogenous COX	33877
prostacyclin	33903
Prostacyclin	33917
the most potent inhibitor of platelet aggregation and a cytoprotective agent against various stresses -LSB- 21 , 22 -RSB-	33933
the most potent inhibitor	33933
platelet aggregation and a cytoprotective agent	33962
platelet aggregation	33962
a cytoprotective agent	33987
various stresses	34018
-LSB- 21 , 22	34035
it	34054
biological half-life time	34079
only 2 -- 3 min	34111
only 2	34111
3 min	34118
Prostacyclin	34125
the blood vessels	34156
the activity of white blood cell and monocyte in the inflammatory reaction	34187
the activity of white blood cell	34187
the activity	34187
white blood cell	34203
monocyte in the inflammatory reaction	34224
monocyte	34224
the inflammatory reaction	34236
Many studies	34263
cytoprotective effects of prostacyclin	34283
cytoprotective effects	34283
prostacyclin	34309
the mechanism	34327
Cytoprotective effects of prostacyclin	34366
Cytoprotective effects	34366
prostacyclin	34392
the function of removing reactive oxygen species -LSB- 43 -RSB-	34419
the function	34419
reactive oxygen species	34444
43 -RSB-	34469
Prostacyclin	34474
certain protective function	34491
spinal cord injury	34523
it	34557
other PGs , which had the function of vasoconstriction and platelet aggregation -LSB- 31 , 44 -RSB-	34573
other PGs	34573
the function of vasoconstriction and platelet aggregation	34594
the function	34594
vasoconstriction and platelet aggregation	34610
-LSB- 31 , 44	34652
Prostacyclin	34662
inflammatory cells	34689
the injured tissues	34728
local inflammatory reaction	34763
-LSB- 28 , 29 -RSB-	34791
The functional characterization of OEC	34801
The functional characterization	34801
OEC	34836
co-culture	34865
neuron-glial cultures	34881
A clear neuroprotective effect of OEC	34904
A clear neuroprotective effect	34904
OEC	34938
OGDtreated cortical neuron-glial cells	34958
Both control OEC and PGIS-OEC	34998
cell death	35048
neuronal survival	35072
Such properties of OECs	35091
Such properties	35091
OECs	35110
them	35128
potential clinical agents able to support injured CNS	35133
potential clinical agents	35133
injured CNS	35175
co-culture with spinal cord neuron-glial cultures	35191
co-culture	35191
spinal cord neuron-glial cultures	35207
spinal cord	35207
neuron-glial cultures	35219
PGIS-OEC	35242
neuronal connection significantly better	35260
neuronal connection	35260
OEC	35306
contrast	35314
microglial number in neuron-glial cultures	35324
microglial number	35324
neuron-glial cultures	35345
PGIS-OEC co-cultures	35396
three week PGIS-OEC grafted spinal cords	35421
three week PGIS-OEC	35421
spinal cords	35449
microglial numbers	35463
those in GFP-OEC grafted spinal cords -LRB- Fig. 6 -RRB- , consistent with co-culture study and our previous report -LSB- 28 -RSB-	35507
those	35507
GFP-OEC grafted spinal cords -LRB- Fig. 6 -RRB- , consistent with co-culture study and our previous report -LSB- 28 -RSB-	35516
GFP-OEC	35516
spinal cords -LRB- Fig. 6 -RRB- , consistent with co-culture study and our previous report	35532
spinal cords -LRB- Fig. 6 -RRB-	35532
spinal cords	35532
Fig. 6	35546
co-culture study and our previous report	35571
co-culture study	35571
our previous report	35592
28 -RSB-	35613
The prostacyclin receptor -LRB- IP receptor -RRB-	35618
The prostacyclin receptor	35618
IP receptor	35645
a G protein -- coupled receptor that is primarily coupled to the activation of adenylate cyclase , which catalyzes the formation of 3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35661
a G protein	35661
coupled receptor that is primarily coupled to the activation of adenylate cyclase , which catalyzes the formation of 3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35674
coupled receptor	35674
the activation of adenylate cyclase , which catalyzes the formation of 3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35720
the activation	35720
adenylate cyclase , which catalyzes the formation of 3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35738
adenylate cyclase	35738
the formation of 3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35773
the formation	35773
3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB- , a key messenger for axon regeneration	35790
3 ′ ,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB-	35790
3 ′	35790
,5 ′ cyclic adenosine monophosphate -LRB- cAMP -RRB-	35792
,5 ′ cyclic adenosine monophosphate	35792
cAMP	35828
a key messenger for axon regeneration	35835
a key messenger	35835
axon regeneration	35855
The benificial effect of PGIS-OEC in co-cultures or in grafted spinal cord	35874
The benificial effect	35874
PGIS-OEC in co-cultures or in grafted spinal cord	35899
PGIS-OEC	35899
co-cultures	35911
grafted spinal cord	35929
part	35960
increase of celllar cAMP	35983
increase	35983
celllar cAMP	35995
microglial activation/infiltration	36018
prostacyclin	36056
another possible effect	36072
microglia	36104
a pivotal role in inflammatory reaction and the suggested effects from our previous reports	36120
a pivotal role in inflammatory reaction	36120
a pivotal role	36120
inflammatory reaction	36138
the suggested effects from our previous reports	36164
the suggested effects	36164
our previous reports	36191
-LSB- 28 , 29 -RSB-	36212
it	36231
receptor subtype of prostacyclin -LRB- IP1 or IP2 -RRB-	36265
receptor subtype	36265
prostacyclin -LRB- IP1 or IP2 -RRB-	36285
prostacyclin	36285
IP1 or IP2	36299
IP1	36299
IP2	36306
these effects	36326
Further studies	36341
the role played by downstream molecules in the inhibition of microglial number/activation	36381
the role	36381
downstream molecules in the inhibition of microglial number/activation	36400
downstream molecules	36400
the inhibition of microglial number/activation	36424
the inhibition	36424
microglial number/activation	36442
adult rat suffered from spinal cord injury	36478
adult rat	36478
spinal cord injury	36502
5-10 %	36522
fibers at the lesion center	36535
fibers	36535
the lesion center	36545
partially or fully functional recovery in the paralyzed hind limbs	36574
fully functional recovery in the paralyzed hind	36587
fully functional recovery	36587
the paralyzed hind	36616
rats -LSB- 45 -RSB-	36644
rats	36644
45 -RSB-	36650
we	36666
the model of severe SCI	36675
the model	36675
severe SCI	36688
complete transection	36704
the effect of the experimental therapy	36737
the effect	36737
the experimental therapy	36751
This study	36777
spinal cord	36805
5 mm segment of the spinal cord being removed	36848
5 mm segment	36848
the spinal cord being removed	36864
the spinal cord	36864
it	36904
OEC	36929
stumps	36938
the distance between two stumps	36951
the distance	36951
two stumps	36972
5 mm	36987
Fibrin glue	36993
a bridge to connect CNS tissue -LSB- 46 -RSB-	37022
CNS tissue -LSB- 46 -RSB-	37042
CNS tissue	37042
46 -RSB-	37054
the present study	37062
fibrin glue	37081
the transplanted OEC	37116
two spinal stumps	37151
The OEC embedded in fibrin glue	37170
The OEC	37170
fibrin glue	37190
new regenerating axon re-grow into the distal stump of spinal cord	37213
new regenerating axon re-grow	37213
the distal stump of spinal cord	37248
the distal stump	37248
spinal cord	37268
Previous studies	37281
OEC graft	37313
the host spinal cord	37340
axon	37383
-LSB- 17 , 47 -RSB-	37388
the fibrin glue-mixed OEC	37421
the host spinal cord	37476
we	37498
AdGFP gene transfer	37509
OEC	37532
cell grafting	37543
The result	37558
OEC expressing GFP	37581
OEC	37581
GFP	37596
one and three weeks after surgery	37618
one and three weeks	37618
surgery	37644
one week postgraft	37656
OEC	37676
the transplanted site and the edge of the transplanted area	37699
the transplanted site	37699
the edge of the transplanted area	37725
the edge	37725
the transplanted area	37737
the cells	37764
the rostral/caudal stumps of the spinal cord	37795
the rostral/caudal stumps	37795
the spinal cord	37824
the result of Ruitenberg -LSB- 48 -RSB-	37857
the result	37857
Ruitenberg -LSB- 48 -RSB-	37871
Ruitenberg	37871
48 -RSB-	37883
OEC	37896
spinal cord stumps	37914
three weeks postgraft	37936
GFP -LRB- + -RRB- OEC was found in both rostral/caudal stumps of the spinal cord about 4 -- 5 mm	37972
GFP	37972
+	37977
both rostral/caudal stumps of the spinal cord about 4 -- 5 mm	37997
rostral/caudal stumps of the spinal cord about 4	38002
rostral/caudal stumps	38002
the spinal cord about 4	38027
the spinal cord	38027
4	38049
5 mm	38051
the injured epicenter at third weeks	38066
the injured epicenter	38066
third weeks	38091
post-graft -LRB- Fig. 5g-i -RRB- ,	38103
post-graft	38103
Fig. 5g-i	38115
our previous result	38139
34 -RSB-	38160
It	38165
OEC in the injured epicenter	38197
OEC	38197
the injured epicenter	38204
apoptosis	38236
OEC that migrated into the rostral/caudal stumps	38252
OEC	38252
the rostral/caudal stumps	38275
a less hostile environment	38321
The recombinant Ad we used	38349
The recombinant Ad	38349
we	38368
the first generation	38380
the expression of the encoding gene	38405
the expression	38405
the encoding gene	38423
AdGFP or AdPGIS used in this study	38456
AdGFP or AdPGIS	38456
this study	38480
a phosphoglycerate kinase promoter that could drive transgene expression with less immune reaction	38517
a phosphoglycerate kinase promoter	38517
transgene expression	38569
less immune reaction	38595
There	38617
no significant side effects in SCI rats	38628
no significant side effects	38628
SCI rats	38659
Ad transduced cells	38673
Ad	38673
cells	38687
Acute SCI	38694
a devastating event	38707
a secondary degenerative process	38731
acute SCI	38787
The secondary cascade	38798
hours and days	38832
the initial insults	38853
further neurological damage	38886
Intervention to block secondary pathological cascade after injury	38915
secondary pathological cascade	38937
injury	38974
cells	38993
function	39012
The grafted PGIS-OEC in the injured cords	39022
The grafted PGIS-OEC	39022
the injured cords	39046
PGIS -LRB- up to 3 weeks -RRB- that increased prostacyclin synthesis and exerted its neuroprotective and anti-inflammatory effects	39091
PGIS	39091
up to 3 weeks	39097
prostacyclin synthesis	39127
its neuroprotective and anti-inflammatory effects	39162
the present study	39216
axon regeneration	39235
two axonal systems : -LRB- i -RRB- descending corticospinaltract -LRB- CST -RRB- visualized by anterograde axonal tract tracer WGAHRP and -LRB- ii -RRB- descending serotonergic -LRB- 5-HT -RRB- tract , visualized by immunohistochemistry	39269
two axonal systems	39269
-LRB- i -RRB- descending corticospinaltract -LRB- CST -RRB- visualized by anterograde axonal tract tracer WGAHRP and -LRB- ii -RRB- descending serotonergic -LRB- 5-HT -RRB- tract , visualized by immunohistochemistry	39289
-LRB- i -RRB-	39289
corticospinaltract -LRB- CST -RRB- visualized by anterograde axonal tract tracer WGAHRP	39304
corticospinaltract	39304
CST	39324
anterograde axonal tract tracer WGAHRP	39343
anterograde	39343
axonal tract tracer WGAHRP	39355
serotonergic -LRB- 5-HT -RRB- tract , visualized by immunohistochemistry	39402
serotonergic -LRB- 5-HT -RRB- tract	39402
5-HT	39416
immunohistochemistry	39443
WGA-HRP	39465
the hindlimb area of the sensory motor cortex	39507
the hindlimb area	39507
the sensory motor cortex	39528
The main pathway of controlling motor in spinal cord	39554
The main pathway	39554
controlling motor in spinal cord	39574
controlling motor	39574
spinal cord	39595
the corticospinal tracts of primary motor cortex	39627
the corticospinal tracts	39627
primary motor cortex	39655
Caudal axons labeled by WGA-HRP	39677
Caudal axons	39677
WGA-HRP	39701
thoracic level	39730
12	39745
two of the AdPGIS-OEC grafted animals -LRB- ~ 40 % -RRB-	39769
two	39769
the AdPGIS-OEC grafted animals -LRB- ~ 40 % -RRB-	39776
the AdPGIS-OEC	39776
animals -LRB- ~ 40 % -RRB-	39799
animals	39799
40 %	39809
The WGA-HRP-labeled axons	39815
the original pathway , between gray matter and white matter	39852
the original pathway	39852
between gray matter	39874
white matter	39898
we	39921
any regenerated axons located in the edge of white matter of spinal cord as demonstrated in the study of Ramon-Cueto et al. -LSB- 16 -RSB-	39939
any regenerated axons	39939
the edge of white matter of spinal cord	39972
the edge	39972
white matter of spinal cord	39984
white matter	39984
spinal cord	40000
the study of Ramon-Cueto et al. -LSB- 16 -RSB-	40031
the study	40031
Ramon-Cueto et al. -LSB- 16 -RSB-	40044
Ramon-Cueto et al. -LSB-	40044
the other hand	40072
the decending serotonergic fibers	40088
dorsal horn , medicinerea and ventral horn	40142
dorsal horn	40142
medicinerea	40155
ventral horn	40171
spinal cord -LSB- 49 -RSB-	40187
spinal cord	40187
49 -RSB-	40200
It	40205
sensory , motor and autonomic functions via serotonin receptors -LSB- 48 -RSB-	40225
sensory	40225
motor	40234
autonomic functions via serotonin receptors -LSB- 48 -RSB-	40244
autonomic functions	40244
serotonin receptors -LSB- 48 -RSB-	40268
serotonin receptors	40268
48 -RSB-	40289
the 5-HT neurons projecting to ventral horn	40308
the 5-HT neurons	40308
ventral horn	40339
the functional recovery	40367
spinal cord injury -LSB- 50 -RSB-	40397
spinal cord injury	40397
50 -RSB-	40417
Raphe nuclei	40422
the only source of serotonergic fibers	40440
the only source	40440
serotonergic fibers	40459
Thirty days	40480
complete spinal cord transection	40498
the caudal stumps of the spinal cord tissue	40532
the caudal stumps	40532
the spinal cord tissue	40553
HT	40606
2 -RSB-	40610
immunohistochemistrical staining of 5-HT	40620
immunohistochemistrical staining	40620
5-HT	40656
serotonergic axons	40689
the lesion site	40728
the caudal stumps of the spinal cord	40756
the caudal stumps	40756
the spinal cord	40777
the present study	40797
regenerating 5-HT -LRB- + -RRB- fibers could be found in the distal stump of one -LRB- 16.7 % -RRB- of OEC-grafted and three -LRB- 60 % -RRB- of AdPGISOEC	40816
regenerating 5-HT	40816
+	40835
the distal stump of one -LRB- 16.7 % -RRB- of OEC-grafted and three -LRB- 60 % -RRB- of AdPGISOEC	40863
the distal stump	40863
one -LRB- 16.7 % -RRB- of OEC-grafted and three -LRB- 60 % -RRB- of AdPGISOEC	40883
one -LRB- 16.7 % -RRB- of OEC-grafted	40883
one -LRB- 16.7 % -RRB-	40883
one	40883
16.7 %	40888
OEC-grafted	40898
three -LRB- 60 % -RRB- of AdPGISOEC	40914
three -LRB- 60 % -RRB-	40914
three	40914
60 %	40921
AdPGISOEC	40929
SCI rats	40947
the non-treated SCI animals	40960
there	40989
no serotonergic axonal regeneration found in the distal stump -LRB- 0 % -RRB-	40999
no serotonergic axonal regeneration	40999
the distal stump -LRB- 0 % -RRB-	41044
the distal stump	41044
0 %	41062
addition	41070
all regenerating axons	41080
the gray matter of distal spinal cord	41124
the gray matter	41124
distal spinal cord	41143
more glial cells	41173
the white matter , which was not hospitable for regeneration of injured nerve tracts	41204
the white matter	41204
regeneration of injured nerve tracts	41251
regeneration	41251
injured nerve tracts	41267
OEC graft study in Lu et al. -LSB-	41301
OEC graft study	41301
Lu et al. -LSB-	41320
51 -RSB- which showed 5-HT -LRB- + -RRB- axon in the distal spinal cord , from 3.6 mm to the farthest 6 mm , the 5-HT -LRB- + -RRB- axon found in the present study	41331
51 -RSB-	41331
+	41354
axon in the distal spinal cord , from 3.6 mm to the farthest 6 mm , the 5-HT	41357
axon	41357
the distal spinal cord	41365
3.6 mm to the farthest 6 mm , the 5-HT	41394
3.6 mm to the farthest 6 mm	41394
3.6 mm	41394
the farthest 6 mm	41404
the farthest	41404
the 5-HT	41423
+	41433
axon found in the present study	41436
axon	41436
the present study	41450
1 mm	41494
the transected site	41504
the amount	41529
We	41554
it	41568
the different transection gap between two stumps in the experiment	41586
the different transection gap	41586
two stumps in the experiment	41624
two stumps	41624
the experiment	41638
we	41657
the distance in between two stumps	41667
the distance	41667
between two stumps	41683
the growing distance of the axon	41708
the growing distance	41708
the axon	41732
BBB scale -LSB- 40 -RSB-	41759
BBB scale	41759
40 -RSB-	41770
the motor functional recovery level of the hind limbs in rats	41802
the motor functional recovery level	41802
motor	41806
the hind limbs in rats	41841
the hind limbs	41841
rats	41859
SCI	41870
The advantage of it	41875
The advantage	41875
it	41892
it	41904
the animals used in the experiment	41931
the animals	41931
the experiment	41951
advance	41996
The behavioral result observed in the present study	42005
The behavioral result	42005
the present study	42039
there	42069
no difference between groups	42079
no difference	42079
groups	42101
the fourth week postinjury	42114
the sixth week	42148
the difference	42164
the groups	42196
transplanted OEC or Ad-PGIS-OEC and the control group	42212
transplanted OEC or Ad-PGIS-OEC	42212
the control group	42248
We	42267
it	42284
the transected interval -LRB- 5 mm -RRB- between two stumps in the experiment	42302
the transected interval -LRB- 5 mm -RRB-	42302
the transected interval	42302
5 mm	42327
two stumps in the experiment	42341
two stumps	42341
the experiment	42355
It	42371
about 4	42385
6 weeks for the axon to grow across this interval	42393
6 weeks	42393
the axon to grow across this interval	42405
this interval	42429
the average BBB score	42451
1 point	42490
4 weeks	42505
the sixth week	42520
it	42536
significant progress	42548
addition	42573
we	42583
none of the animals	42597
none	42597
the animals	42605
coordinate movement between fore and hind limbs	42621
coordinate movement	42621
fore and hind limbs	42649
this twelve-week behavior observation	42672
the hind limbs	42715
the weight	42745
Ramon-Cueto et al. -LSB- 16 -RSB-	42757
Ramon-Cueto et al. -LSB-	42757
OEC	42790
two stumps of transected spinal cord	42799
two stumps	42799
transected spinal cord	42813
the function of hind limbs	42851
the function	42851
hind limbs	42867
the weight	42919
sevenmonth behavior observation	42936
the functional recovery	42981
limit in this twelve-week study	43009
limit	43009
this twelve-week study	43018
the functional recovery	43042
we	43090
longer survival	43104
observation period	43120
